Measuring Brain Iron In Healthy Controls And Accessing Venous Abnormalities In Parkinson\u27s Disease Using Mri by Liu, Manju
Wayne State University
Wayne State University Dissertations
1-1-2014
Measuring Brain Iron In Healthy Controls And
Accessing Venous Abnormalities In Parkinson's
Disease Using Mri
Manju Liu
Wayne State University,
Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations
This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in
Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState.
Recommended Citation
Liu, Manju, "Measuring Brain Iron In Healthy Controls And Accessing Venous Abnormalities In Parkinson's Disease Using Mri"
(2014). Wayne State University Dissertations. Paper 989.
MEASURING BRAIN IRON IN HEALTHY CONTROLS AND ASSESSING VENOUS 
ABNORMALITIES IN PARKINSON’S DISEASE USING MRI 
 
by  
MANJU LIU 
 DISSERTATION 
 Submitted to the Graduate School  
of Wayne State University,  
Detroit, Michigan 
 in partial fulfillment of the requirements  
for the degree of 
 DOCTOR OF PHILOSOPHY 
2014 
MAJOR: BIOMEDICAL ENGINEERING 
Approved by:                      
_________________________________________  
 Advisor                                                             Date  
_________________________________________  
_________________________________________  
 _________________________________________ 
_________________________________________ 
 
 
 
ii 
 
DEDICATION 
This dissertation is dedicated to my parents: 
Jianwu Liu 
Guizhi Xi 
  
 
 
iii 
 
ACKNOWLEDGMENTS 
I would like to thank three important groups of people, without whom this dissertation would not 
have been possible: my committee, my wonderful lab-mates, and my family. 
First of all, I would like to express my sincere thanks and deepest appreciation to my supervisor, 
Dr. E. Mark Haacke for his enduring inspiration, patient, guidance, support and encouragement 
all through my study in the past six years. I’m so blessed to have a supervisor who is one of the 
most important scientists in this field and also cares about his students. I cannot thank him 
enough for what he has done for me. 
I would like to thank the members of my dissertation committee - not only for their time and 
extreme patience but also for all the valuable comments and suggestions that they provided for 
me during my research. To Dr. Jaladhar Neelavalli, I thank for the wonderful MRI courses he 
offered. He is always there available to answer questions. I learned a great deal from his courses 
and enjoyed them all. Thanks to Dr. Weiping Ren for his clearly explaining physiology during 
the courses. His expertise on physiology helped my understanding about the iron metabolism in 
human brain. Thanks to Dr. Zhifeng Kou, his support, attention to detail, hard work, and 
scholarship have set an example I hope to match someday. To Dr. Indrin Chetty, I thank for all 
his advice, also for his flexibility in scheduling, gentle encouragement and relaxed demeanor 
made for a good working relationship and the impetus for me to finish. 
To my lab-mates, thanks for the fun and support. To Dr. Weili Zheng, Yongquan Ye, Saifeng 
Liu, Yanwei Miao, Wei Feng and Charbel Habib, for their supports and guidance to my projects. 
Whenever I encountered problems, they are always the right people to consult to bring new ideas. 
I also want to thank many others in the lab, Rachel Martis Laze, Jing Jiang, Yi Zhong, Ying 
 
 
iv 
 
Wang, Sagar Buch, Jin Tang, Meng Li, Yang Xuan, Norman Cheng, Ching-Yi Hsieh, Emil 
Eugen Pacurar, Yimin Shen, Jessy Mouannes-Srour, Jiani Hu, Judith Farah, Lisa Brownschidle, 
Paul Kokeny, Tilak Gattu, Pavan Jella, Uday Krishnamurthy, Zahid Latif, and Yashwanth 
Katkuri for their support and friendship.  
Finally, the most important, I want to thank my parents, Jianwu Liu and Guizhi Xi, my husband, 
Ning Wen, my mother-in-law, Yuanqin Huang, my uncle, Jianju Liu and my lovely children, 
Jacob Wen and Anna Wen. Thank you all for your constant support and endless love through the 
ups and downs of my academic career. It has been bumpy at times, but your confidence in me 
has enhanced my ability to get through it all and succeed in the end. 
 
 
 
 
  
 
 
v 
 
TABLE OF CONTENTS 
Dedication……… ........................................................................................................................... ii 
Acknowledgments.......................................................................................................................... iii 
List of tables… .............................................................................................................................. vii 
List of figures ............................................................................................................................... viii 
Abbreviation list.............................................................................................................................. x 
Chapter One    Introduction ........................................................................................................ 1 
1.1 Background and Project Motivation .............................................................. 1 
1.2 Project Aims: .................................................................................................... 2 
Chapter Two    Basic concepts of gradient echo imaging, phase, and quantitative 
susceptibility mapping ........................................................................................... 4 
2.1 Gradient echo imaging ..................................................................................... 4 
2.2 Magnetic Susceptibility and Phase ............................................................... 13 
Chapter Three    Brain iron and iron quantification ............................................................... 24 
3.1 Basic brain iron physiology ........................................................................... 25 
3.2 MRI methods for Iron quantification ........................................................... 27 
Chapter Four    Correlation of putative iron content as represented by changes in phase 
and    with R2* age in deep gray matter nuclei of healthy adults .................... 34 
Chapter Five    Assessing the changes of susceptibility in the human brain nuclei over              
lifespan and investigating the correlation between susceptibility and in vivo 
iron content ........................................................................................................... 66 
Chapter Six    Patterns of chronic venous insufficiency in the dural sinuses and draining 
extracranial veins and their relationship with white matter hyperintensities 
for patients with parkinson's disease .................................................................. 89 
Chapter Seven    Conclusions and future directions .............................................................. 108 
Appendix A: Modified Visual Rating Scale for WMH Proposed by Scheltens et al ................. 113 
References…. .............................................................................................................................. 115 
 
 
vi 
 
Abstract ………………………………………………………………………………………...130 
Autobiographical Statement ........................................................................................................ 132 
 
 
  
 
 
vii 
 
LIST OF TABLES 
Table 2.1: Expressions for field inside and outside a uniform sphere and an infinitely long    
cylinder ....................................................................................................................... 16 
Table 3.1: Correlation between susceptibility mapping and iron concentration .......................... 33 
Table 4.1: Threshold values for the regional separation ............................................................... 40 
Table 4.2: Slopes of phase and magnitude iron measures as a function of age in the two 
hemispheres................................................................................................................. 54 
Table 4.3: The orders of high to low iron deposition over time. .................................................. 57 
Table 4.4: Comparison between the two hemispheres of phase related iron measures ................ 63 
Table 4.5: Comparison between the two hemispheres of magnitude related iron measures ........ 64 
Table 5.1: Statistics table of the susceptibility comparisons between the left and right 
hemispheres in difference intervals. ........................................................................... 75 
Table 5.2: The parameters of the linear fitting equations for Susceptibility vs. Age ................... 76 
Table 5.3: Reported linear correlation between iron related parameters and age. ........................ 82 
Table 6.1: MR imaging parameters for different sequences. ........................................................ 92 
 
 
 
   
 
 
viii 
 
LIST OF FIGURES  
Figure 2.1: 3D GRE pulse sequence diagram ............................................................................... 10 
Figure 2.2: The corresponding k-space filling mechanism for a simple GRE sequence as            
shown in Figure 2.1. .................................................................................................. 12 
Figure 2.3: Single echo SWI sequence diagram. .......................................................................... 13 
Figure 2.4: Complex representation of a signal vector S in the Real-Imaginary plane. ............... 18 
Figure 2.5: The illustration of the step flow to do homodyne high pass filter .............................. 20 
Figure 2.6: Image processing procedures to generate susceptibility maps ................................... 22 
Figure 4.1: Example boundaries ................................................................................................... 36 
Figure 4.2: An example of a two-ROI analysis in the caudate nucleus. ....................................... 39 
Figure 4.3: A plot of phase iron versus magnitude iron for a series of 100 normal subjects. ...... 43 
Figure 4.4: Putative iron measurement results as a function of age in Putamen. ......................... 45 
Figure 4.5: Putative iron content ................................................................................................... 46 
Figure 4.6: Putative iron ............................................................................................................... 47 
Figure 4.7: Putative iron content ................................................................................................... 48 
Figure 4.8: Putative iron content ................................................................................................... 49 
Figure 4.9: Average iron ............................................................................................................... 50 
Figure 4.10: Average iron ............................................................................................................. 51 
Figure 4.11: Normalized area of high iron content region as a function of age in CN, PT, and 
THA ......................................................................................................................... 52 
Figure 4.12: Normalized area of high iron content region as a function of age in RN,                  
SN and GP ............................................................................................................... 53 
Figure 4.13: Putative iron content in two age intervals ................................................................ 56 
Figure 4.14: Expressing average iron content (iron density) in the PUT for RII ......................... 60 
Figure 4.15: Expressing average iron content (iron density) in the PT for RII ............................ 61 
 
 
ix 
 
Figure 4.16: Expressing average iron content (iron density) in the SN for RII ............................ 62 
Figure 5.1: Example of original phase, background removed phase and susceptibility map ....... 70 
Figure 5.2. Multi-slice 3D ROIs drawn on the QSM maps .......................................................... 72 
Figure 5.3: The average susceptibility for each of the 5 age intervals ......................................... 74 
Figure 5.4: Magnetic susceptibility changes with age in different grey matter nuclei ................. 79 
Figure 5.5: Relationship between magnetic susceptibility and iron concentration ...................... 80 
Figure 6.1:  PCFQ images without (A, B) and with (C, D) vessel contours used for blood flow 
quantification ............................................................................................................. 94 
Figure 6.2: Example of flow parameters of the vessels of interest over a full cardiac cycle ....... 96 
Figure 6.3: A-D: Example cases from each of four categories and different abnormal IJV 
conditions shown in the coronal projection of the 2D TOF images .......................... 98 
Figure 6.4: Distribution and scatter plots of Category, Fd, Fsd, and Fd/Fsd ................................. 101 
Figure 6.5: The distribution of IPD patients and normal controls with low WMH and high        
WMH for different categories ................................................................................. 103 
 
  
 
 
x 
 
ABBREVIATION LIST 
3D CE MRAV: 3D time-resolved contrast-enhanced arteriovenography 
ADHD: Attention Deficit Hyperactivity Disorder 
BBB: Blood-Brain Barrier 
CN: Caudate Nucleus 
CSF: CerebroSpinal Fluid 
DSI: Direct Saturation Imaging 
EJV: External Jugular Veins 
EMF: electromotive force 
Fd/Fsd: the ratio between the dominant and sub-dominant IJVs 
FDRI: Field Dependent Relaxation Rate Increase 
FOV: Field of View 
FQ: Flow Quantification 
FQ: Flow Quantification 
Fsd/TA: normalized sub-dominant IJV flow 
GE: General Electric 
GM: Gray Matter 
GP: Globus Pallidus 
 
 
xi 
 
GRE: Gradient Recalled Echo 
HP: High Pass 
ICPMS: Inductively Coupled Plasma Mass Spectrometry 
IJV: Internal Jugular Vein  
IPD: Idiopathic Parkinson's Disease 
LfR/Lf: Lactoferrin Receptor / Lactoferrin 
LIJV/tA: normalized left IJV flow 
MFC: Magnetic Field Correlation 
MFC: Magnetic Field Correlation 
MinIP: Minimum Intensity Projection 
MIP: Maximum Intensity Projection 
MRA: MR Angiography 
MRA: MR Angiography 
MRI: Magnetic Resonance Imaging 
MS: Multiple Sclerosis 
MTf/sMTf: GPI-anchored Melanotransferrin / soluble Melanotransferrin 
PC: Phase Contrast 
PT: Pulvinar Thalamus 
 
 
xii 
 
PTA: Percutaneous Transluminal Angioplasty 
PUT: Putamen 
PVH: PeriVentricular Hyperintensities 
QSM: Quantitative Susceptibility Mapping 
RF: radio frequency 
RI: low iron content region 
RII: high iron content region 
RN: Red Nucleus 
ROC: Receiver Operator Characteristic 
ROI: Regions Of Interest 
SD: Standard Deviations 
SN: Substantia Nigra 
SPIN: Signal Processing in NMR 
SPU: Siemens Phase Unit 
SSS: Superior Sagittal Sinus 
SWI: Susceptibility Weighted Imaging 
T: Tesla 
T1: Spin Lattice Relaxation Time 
 
 
xiii 
 
T2: Spin-Spin Relaxation Time 
tA: total Arterial flow 
TE: Echo Time 
Tf/TfR: Transferrin / Transferrin Receptor 
THA: Thalamus 
tIJV/tA: normalized total IJV flow 
TOF: Time of Flight 
TR: Repetition Time 
UKPDSBB: United Kingdom PD Society Brain Bank Criteria 
Venc: Velocity Encoding 
WM: White Matter 
WMH: White Matter Hyper Intensity 
XRF: X-Ray Fluorescence 
 
 
 
1 
 
 
 
Chapter One    Introduction 
1.1 Background and Project Motivation 
Iron has long been recognized to play a key role in brain functions such as oxygen transport, 
neurotransmitter synthesis, electron transfer, and myelin production [1, 2]. Despite the positive 
implications, when in a free ferrous form, iron is known to be toxic and can lead to free radical 
production. There has been a growing interest in studying the role of iron in neurodegenerative 
diseases such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease and other 
conditions including aging [1-6]. In healthy people, iron deposition in gray matter and white 
matter structures evolves both temporally and spatially. It has been documented that iron content 
in different brain gray-matter nuclei accumulates at different rates at different ages [7, 8]. It is 
important to have the knowledge of quantitative characterization of brain iron change during 
brain development and aging. This will allow us to gain more insights into the potential 
abnormalities such as iron over-accumulation or iron deficit that involve in the pathophysiologic 
process of various neurodegenerative diseases. Evaluating brain iron changes in normal brains in 
vivo provides a reference for monitoring iron changes in patients both cross-sectionally and 
longitudinally.  
In the last few years, there has been an increasing interest in the role of veins in 
neurodegenerative diseases, [9, 10]. More attention has been paid to the extracranial veins such 
as the internal jugular veins (IJVs) and the azygous veins as being potential sources of venous 
hypertension especially in multiple sclerosis (MS) [11, 12]. The obstructed veins are thought to 
cause venous insufficiency. The use of MR angiography (MRA) and flow quantification (FQ) for 
the study of the vasculature in patients with Parkinson’s disease is a novel concept spurred, in 
part, by our recent work in MS patients [13].  
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Idiopathic Parkinson's disease (IPD) is the second most common neurodegenerative disease and 
the etiology of IPD remains unknown [14]. There are two interesting parallels between IPD and 
MS to consider: both show reduced perfusion [15, 16], and both have regions of high iron 
content in the basal ganglia [17, 18]. The parallels between the two diseases, the suggestion that 
venous insufficiency causes damage to the vessel wall and leads to local extravasation of the 
blood and subsequent increases in local iron content, and the presence of cerebrovascular disease 
in roughly 39% of patients with IPD [19] led us to realize the importance to study the venous 
vascular characters of IPD patients. This will have the potential to open new doors in studying 
the vascular etiology of IPD. 
Moreover, it has been shown that there is an increased presence of white matter hyper intensity 
(WMH) in IPD patients [20]. The suggested causes for these deficits include ischemia and 
venous insufficiency from periventricular venular collagenosis [21-23]. One group found that the 
severity of WMH at baseline was the best predictor of PD progression [24]. This also motivates 
us to study the correlation between WMH and venous abnormalities in IPD.  
1.2 Project Aims: 
In this dissertation, phase and quantitative susceptibility mapping (QSM) will be used for 
measuring iron deposition in normal brain grey matter GM) nuclei to review the age effects, and 
the correlation between susceptibility and in vivo iron concentration will be studied.  
The head and neck major veins’ anatomy and blood flow in Parkinson’s patients will be studied 
and compared with normal controls. White matter hyper intensity volume will be quantified for 
Parkinson’s patients and compared with normal subjects.  
Therefore, the specific aims and hypotheses of this thesis are:  
3 
 
 
 
Specific Aim 1: To establish the baseline of putative iron content in the basal ganglia, mid-brain 
and the thalamus as a function of age in healthy human brains using phase and ΔR2* on the basis 
of susceptibility weighted imaging (SWI).  
Hypothesis 1a: Phase and ΔR2* in the brain grey matter nuclei increase as a function of age.  
Hypothesis 1b: The size of the high iron deposition region increases as a function of age in the 
brain grey matter nuclei.  
Specific Aim 2: To establish the baseline of iron deposition in the basal ganglia, mid-brain and 
the thalamus as a function of age in healthy human brains using QSM derived from SWI phase, 
and find the conversion factor between magnetic susceptibility and in vivo iron concentration.  
Hypothesis 2a: Magnetic susceptibility in the grey matter nuclei increases as a function of age.  
Hypothesis 2b: Linear correlation exists between susceptibility and in vivo iron deposition.  
Specific Aim 3: To investigate the presence of structural and flow abnormalities in the dural 
sinuses and extracranial draining veins in IPD patients and study the correlation between venous 
abnormalities with WMH volume.  
Hypothesis 3a: There is a higher prevalence of abnormal venous anatomy and flow on the left 
side of the brain and neck in IPD patients.  
Hypothesis 3b: WMH volume in patients with IPD is higher than in normal controls.  
Hypothesis 3c: Venous abnormalities correlate with WMH volume. 
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Chapter Two    Basic concepts of gradient echo imaging, phase, and 
quantitative susceptibility mapping 
Chapter overview 
Gradient echo imaging (GRE) is one of the most important MRI sequence types. Rapidly 
collecting high resolution MR imaging with low radio frequency (rf) power deposition becomes 
possible with gradient echo-based MR imaging techniques [25]. In MRI, phase represents the 
spatial magnetic field variations, and the magnetic susceptibility maps can be extracted from 
phase image. Both the phase and magnetic susceptibility can be used for measuring iron owing to 
iron’s paramagnetic character.  
In this chapter, we will briefly introduce the basic aspects of gradient echo imaging that are 
relevant to susceptibility weighted imaging (SWI). We will also touch on the principles of 
susceptibility, phase and how to do quantitative susceptibility mapping from SWI phase images.  
 
2.1 Gradient echo imaging  
Larmor Frequency: 
When placing a particle in a magnetic field, if the nuclear spin of that particle is not zero (in 
multiples of ±1/2), the spin will precess around the external magnetic field axis. The precession 
frequency is the Larmor frequency, which is defined as (we assume a right handed system) [25] 
ሬ߱റ ൌ െߛ ∙ ܤሬറ                                                                                 (2.1) 
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where ω is the precession angular frequency, ߛ is the gyromagnetic ratio of the element, and ܤሬറ is 
the actual field experienced by that particle. 
Proton (hydrogen 1H) is the key element in the human body that produces nuclear magnetic 
resonance signals owing to its non-zero net spin (1/2) and large biological abundance (around 63% 
of the body weight [26]). Each type of element has its own gyromagnetic ratio. The 
gyromagnetic ratio of the proton is 2.675×108 rad/s/T.  
Magnetization Vector: 
For a spin isochromat (a given small enough volume (V) whose external field is constant, so the 
spins in V experience the same phase) with a large number of protons, by summing up all the 
magnetic monument vectors and dividing by V, we get the magnetization vector (magnetic 
moment per volume) [27]. The sum of the magnetization vectors is called net magnetization 
(ܯሬሬറ). ; 
When not taking the proton interactions into account, the Bloch equation is:  
݀ܯሬሬറ
݀ݐ ൌ ߛܯሬሬറ ൈ ܤ଴̂ݖ																																																																																ሺ2.2ሻ 
where ܤ଴ is the strength of the applied magnetic field along z direction (longitudinal).   
The magnetization can be decomposed into the longitudinal and transverse components: 
݀ܯ௭
݀ݐ ൌ 0																																																																																							ሺ2.3ሻ 
݀ܯሬሬറୄ
݀ݐ ൌ ߛܯሬሬറୄ ൈ ܤ଴̂ݖ																																																																												ሺ2.4ሻ 
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Once the magnetization has a transverse component, it will rotate about B଴, and this can be 
detected. An electromotive force (emf) is created in coil through with the spin’s magnetic flux 
sweeps, a consequence of Faraday’s law. The time-dependent form of this current carries the 
information that is eventually transformed into an image of the sample [27].  
 
T1 Process: 
In the external magnetic field, when doing nothing, the net magnetization (ܯ଴) lies along the 
same direction as the main field. So the longitudinal magnetization ܯ௭ is equal to ܯ଴ and the 
transverse magnetization ܯ௫௬ is zero. After tipping the original net magnetization away from the 
main magnetic field by using a radio frequency (rf) pulse, the longitudinal magnetization (ܯ௭) 
will gradually recover to the beginning state. The time which is used to describe this type of 
longitudinal magnetization recovery is called the spin lattice relaxation time (T1), which can be 
determined experimentally [27].  
When taking the spin-lattice interaction into account, equation (2.3) becomes: 
݀ܯ௭
݀ݐ ൌ
1
ܶ1	ሺܯ଴ െܯ௭ሻ																																																																										ሺ2.5ሻ 
By solving the differential equation (2.5), after the application of an rf pulse, the longitudinal 
magnetization can be calculated by:  
ܯ௭ሺݐሻ ൌ ܯ௭ሺ0ሻ݁ି௧/்ଵ ൅ ܯ଴ሺ1 െ ݁ି௧/்ଵሻ																																																						ሺ2.6ሻ 
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T2 process: 
As mentioned in the “Larmor Frequency’ section, the transverse magnetization (ܯ௫௬) rotates 
about the main magnetic field z at the Larmor frequency. Due to the interactions between the 
protons with their environment, spins at different locations may experience a slightly different 
magnetic field which is the combinations of the main field and the local field [27]. This leads 
those isochromats to rotate at different rates. As a result, the transverse magnetization starts to 
dephase and the phase difference increases as time goes. Since the net magnetization is the 
vector sum of each individual magnetization, during the dephasing process the transverse 
magnetization decreases. The time constant which is used to describe the transverse dephasing 
property (returning to transverse magnetization equilibrium, ܯ௫௬ ൌ 0) is called the spin-spin 
relaxation time (T2).  
Therefore, the transverse component of the Bloch equation (2.4) should add another term for T2 
decay:  
݀ܯሬሬറୄ
݀ݐ ൌ ߛܯሬሬറୄ ൈ ܤ଴̂ݖ െ
1
ܶ2ܯሬሬറୄ 																																																																					ሺ2.7ሻ 
The solution for this differential equation is: 
ܯሬሬറୄ ሺݐሻ ൌ ܯሬሬറୄ ሺ0ሻ݁ି௧/்ଶ																																																																										ሺ2.8ሻ 
Both of the T1 and T2 processes occur at the same time. T2 is always less than or equal to T1.  
There are basically two sources leading to the transverse magnetization decay. One is from the 
molecular interactions which is described by T2, and the other is from the variations in ܤ଴, which 
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is described by T2'. The combined time constant is T2*. The relation between those time 
constants is: 
1
ܶ2∗ ൌ
1
ܶ2 ൅
1
ܶ2′																																																																																		ሺ2.9ሻ 
The inversion of the relaxation times (T2, T2', T2*) are call relaxation rates (R2=1/T2, R2'=1/T2', 
R2*=1/T2*). So, 
ܴ2∗ ൌ ܴ2 ൅ ܴ2ᇱ																																																																															ሺ2.10ሻ 
The rule of thumb is that the magnetization loss due to T2' can be recovered in Spin Echo 
sequence but not in Gradient Recalled Echo sequence (GRE), while the magnetization loss due 
to T2 can’t be recovered no matter what sequence is applied.   
 
Fourier transform MRI: 
With the neglect of relaxation effects and demodulating frequency of ߱଴, the MRI signal is 
ݏሺݐሻ ൌම݀ݔ	݀ݕ	݀ݖ ߩሺݔ, ݕ, ݖ, ሻ݁௜థಸሺ௫,௬,௭,௧ሻ																																																					ሺ2.11ሻ 
where ߩሺݔ, ݕ, ݖሻ is the effective spin density, ߶ீሺݔ, ݕ, ݖ, ݐሻ is the accumulated phase determined 
by the three orthogonal linear gradient fields G୶ሺݐሻ, G୷ሺݐሻ, and G୸ሺݐሻ. 
߶ሺݎറ, ݐሻ ൌ െߛ ∙ ∆ܤሺݎറሻ ∙ ݐ ൌ െߛ ∙ ܩሺݎറ, ݐሻݎറ ∙ ݐ																																																								ሺ2.12ሻ 
߶ீሺݔ, ݕ, ݖ, ݐሻ ൌ െߛሾ׬ ݀ݐᇱܩ௫ሺݐᇱሻݔ௧଴ ൅ ׬ ݀ݐᇱܩ௬ሺݐᇱሻݕ
௧
଴ ൅ ׬ ݀ݐᇱܩ௭ሺݐᇱሻݖ
௧
଴ ሿ                         (2.13) 
with ൌ ߛ/2ߨ , we define 
9 
 
 
 
݇௫ሺݐሻ ൌ ߛ ׬ ݀ݐᇱܩ௫ሺݐ′ሻ௧଴ ,						݇௬ሺݐሻ ൌ ߛ ׬ ݀ݐᇱܩ௬ሺݐ′ሻ
௧
଴ ,							݇௭ሺݐሻ ൌ ߛ ׬ ݀ݐᇱܩ௭ሺݐ′ሻ
௧
଴                 (2.14)   
Equation (2.11) becomes  
ݏ൫݇௫, ݇௬, ݇௭൯ ൌ ∭݀ݔ	݀ݕ	݀ݖ ߩሺݔ, ݕ, ݖሻ݁ିଶగ௜ሺ௞ೣ௫ା௞೤௬ା௞೥௭ሻ                             (2.15) 
Therefore, by nature, the MRI signal is the Fourier transform of the effective spin density. The 
MRI data are collected in k-space. Each k-space point is a complex number collected with real 
and imaginary channels. Then by preforming the inverse Fourier transform to the complex k-
space, the effective spin density distribution and phase can be reconstructed.  
 
GRE sequence diagram: 
After applying the excitation rf pulse, the transverse magnetization starts to dephase. There are 
basically two ways to refocus the spins where an echo is formed. One way is to employ a π-pulse, 
which is called spin echo; and the other way is to apply a dephasing gradient followed by a 
rephasing gradient with the same amplitude and duration, which is called gradient echo.  
Gradient echo imaging is one of the most important and frequently used sequences in modern 
MRI. With the GRE technique, it becomes possible to collect MRI data rapidly with high spatial 
resolution and low rf power deposition [25].  
Figure 2.1 shows a typically 3D single-echo GRE sequence diagram. The corresponding k-space 
trajectory for an example slice is shown in Figure 2.2. The data are being sampled (filling the k-
space) when the ADC is on.  
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Figure 2.1: 3D GRE pulse sequence diagram. rf = radio frequency, Gୱ= slab select gradient, G୮= 
phase encoding gradient, Gோ= readout gradient, ADC = analog to digital converter, TE = echo 
time, Tୱ=sampling time. ݐଶ െ ݐଵ ൌ ݐଷ െ ݐଶ ൌ ௦ܶ/2. 
In Figure 2.2, assuming the maximum amplitude of the phase encoding gradient G୮ is G୮,୫ୟ୶, the 
increment of G୮ between two continuous TRs is ∆G୮, the duration of each G୮ is τ୮, at t ൌ tଶ, 
according to Eq. (2.14), k୷ and k୶ of the first data point collected in k-space is 
݇௬ ൌ െߛܩ௣,௠௔௫ ∙ ߬௣ ൌ െ݇௬,௠௔௫																																																																ሺ2.16ሻ 
݇௫ ൌ െߛܩோ ∙ ሺݐଶ െ ݐଵሻ ൌ െ݇௫,௠௔௫																																																														ሺ2.17ሻ 
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k୶ of other data points during Tୱ is 
݇௫ሺݐሻ ൌ െߛܩோ ∙ ሺݐଶ െ ݐଵሻ ൅ ߛܩோ ∙ ሺݐ െ ݐଶሻ					ݐ ൒ ݐଶ																																													ሺ2.18ሻ 
At ݐ ൌ ݐଷ , we have ݐଶ െ ݐଵ ൌ ݐଷ െ ݐଶ ൌ ௦ܶ/2, so according to Eq. (2.18) ݇௫ሺݐଷሻ ൌ 0,	where a 
gradient echo is formed. The time duration from the rf excitation to tଷ is defined as echo time 
(TE). The time duration between two successive rf pulses is called repetition time (TR). In the 
example case shown in Figure 2.1, one k-space line is filled in each TR. During Tୱ, N୶ points are 
sampled symmetrically about k୶ ൌ 0. By varying G୮ and Gୱ, the whole 3D k-space will be filled.  
 
Steady-state incoherent gradient echo imaging:  
The sequence introduced in Figure 2.1 is a simplified GRE sequence. Practically, prior to the 
application of the next rf pulse, the transverse magnetization left from the previous excitation 
should be handled. We will consider only the spoiled gradient echo sequence in which the 
remnant transverse magnetization is dephased at the end of each excitation cycle. This approach 
leads to a lack of coherence in the transverse magnetization, and the longitudinal component is 
the only coherence for the next excitation [28]. There are several methods to achieve spoiling, 
such as by using variable high amplitude gradients (gradient spoiling), and/or by shifting the rf 
pulse phase (usually the rotation angle is set to 117°) from one excitation to the next (rf spoiling) 
[25].  
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Figure 2.2: The corresponding k-space filling mechanism for a simple GRE sequence as shown 
in Figure 2.1.  
 
Magnetization equilibrium can be reached by repeating the application of rf pulses. For steady-
state incoherent gradient echo imaging, the voxel signal can be written as [27]:  
ߩොሺߠ, ܶܧ, ܴܶሻ ൌ ߩ଴ sinሺߠሻ 1 െ ܧଵ1 െ cosሺߠሻܧଵ ܧଶ																																					（2.19）	 
where ρ଴ is the spin density of a given voxel, ܧଵ ൌ ݁ି்ோ/்ଵ, and ܧଶ ൌ ݁ି்ா/்ଶ∗.  
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Sequence diagram of Susceptibility Weighted Imaging (SWI): 
SWI is a type of 3D steady-state incoherent gradient echo imaging. Besides that, in order to 
reduce the phase effect from blood flow, flow compensation gradients in the three encoding 
directions are applied [25]. The single echo SWI sequence diagram is shown in Figure 2.3.  
 
Figure 2.3: Single echo SWI sequence diagram. Flow compensation is in all three directions. 
Gୱ = slab selection/partition encoding gradient, G୮ = phase encoding gradient, Gୖ = readout 
gradient.  
 
2.2 Magnetic Susceptibility and Phase  
Magnetic field and its perturbation due to substances inside the field  
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When an external magnetic field passes through a substance, different substances will show 
different macroscopic behaviors. Basically, the substance will get magnetized and the field inside 
and outside will be perturbed. Magnetic susceptibility (χ) is the tissue property which describes 
how the material is magnetized when exposed under a magnetic field and how the magnetic field 
is changed by the material. Based on the induced magnetization, materials are categorized into 
diamagnetic, paramagnetic and ferromagnetic materials [29]. The magnetic moment of a 
diamagnetic material aligns anti-parallel to the main magnetic field (negative χ); the magnetic 
moment of a paramagnetic material aligns parallel to the main field (positive χ ); and 
ferromagnetic material creates its own magnetic field even without an external field (positive 
constant magnetization Mሬሬሬറ) [29]. 
Since the human body is mainly made of water by weight, susceptibility of water is used as a 
reference which is approximately -9 parts per million (ppm) relative to vacuum. In this thesis, 
when we say something being ‘diamagnetic’ or ‘paramagnetic’ actually means being more 
diamagnetic or more paramagnetic than water. Iron is strongly paramagnetic, as a result it can be 
easily detected with MRI.  
A uniform magnetic field can be defined by 
ܤሬറ଴ ൌ ߤ଴ܪሬറ																																																																												ሺ2.20ሻ 
When an object is placed in this external uniform field, the magnetic field inside the material will 
become 
ܤሬറ ൌ ߤ଴൫ܪሬറ ൅ ܯሬሬറ൯																																																																					ሺ2.21ሻ 
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where ܤሬറ  is the magnetic field in Tesla, ܪሬറ  is called magnetic field strength in Ampere/meter 
(A/m), ܯሬሬറ is the magnetization either permanent or induced, ܯሬሬറ  and ܪሬറ have the same unit, and μ଴ 
is the absolute permeability of the free space (4π ൈ 10଻	Tm/A).  
The induced magnetization ܯሬሬറ relates to ܪሬറ by the magnetic susceptibility χ: 
ܯሬሬറ ൌ ߯ܪሬറ																																																																														ሺ2.22ሻ 
So by combing Eq. (2.21) and Eq. (2.22), the magnetic field inside the substance can be written 
as (χ ≪ 1): 
ܤሬറ ൌ ߤ଴ሺ1 ൅ ߯ሻܪሬറ				or				ܤሬറ ൌ ൬1 ൅ ߯߯ ൰ ߤ଴ܯሬሬറ ൎ ߤ଴ܯሬሬറ/߯																																												ሺ2.23ሻ 
The magnetic field outside the substance will also be perturbed due to the induced magnetization. 
The solution of the perturbed field depends on the induced magnetization and the shape and 
volume of the object [25].  
The magnetic field inside and outside a uniform sphere and an infinitely long cylinder has been 
derived analytically, which are shown in Table 2.1 [25]. 
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Table 2.1: Expressions for field inside and outside a uniform sphere and an infinitely long 
cylinder [25] 
 Internal Field External Field 
Sphere ܤ଴ ܤ଴ ൅ ߯ܤ଴3 ∙
ܽଷ
|ݎറ|ଷ ∙ ሺ3 ܿ݋ݏ
ଶ ߠ െ 1ሻ 
Cylinder ܤ଴ ൅ ߯ܤ଴6 ∙ ሺ3 ܿ݋ݏ
ଶ ߠ െ 1ሻ ܤ଴ ൅ ߯ܤ଴2 ∙
ܽଶ
|ݎറ|ଶ ∙ sin
ଶ ߠ ܿ݋ݏ2߶ 
In this table, B଴ is the external uniform magnetic field applied along the z-direction. θ is the 
angle between the position vector rറ and the main magnetic field for the sphere case, or between 
the long axis of the cylinder and the main field for the cylinder case. ϕ	is the polar angle 
substanded by rറ on the plan perpendicular to the long axis of the cylinder. rറ is the position vector. 
a is the radius of the sphere or the cylinder.  
 
Phase 
In MRI, phase is used to encode the special information. In the rotating frame, no phase 
accumulation is seen. Phase from the encoding gradients is removed during signal modulation. 
Thus, phase value at a given point in an MR image is sensitive to the local magnetic field 
perturbation (∆ܤሺݎറሻ) relative to the main field [25]: 
߮ሺݎറሻ ൌ ∆߱ሺݎറሻ ∙ ܶܧ ൌ െߛ ∙ ∆ܤሺݎറሻ ∙ ܶܧ																																																										ሺ2.24ሻ 
where TE is the echo time where the signal is acquired.  
The phase image contains all the field information, macroscopic and microscopic. The 
macroscopic fields come from the geometry of the big objects such as brain, air-tissue interface 
around the sinus in the brain, and inhomogeneities in the main magnetic field. The microscopic 
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fields are the ones we are usually interested in, the local susceptibility distribution [30]. Phase 
can be summarized as:  
߮ ൌ െߛ ∙ ൫∆ܤ௠௔௜௡	௙௜௘௟ௗ ൅	∆ܤ௖௦ ൅	∆ܤ௚௟௢௕௔௟	௚௘௢௠௘௧௥௬ ൅ ∆ܤ௟௢௖௔௟	௦௨௦௖௘௣௧௜௕௜௟௜௧௬൯ ∙ ܶܧ						ሺ2.25ሻ                    
where ∆ܤ௖௦ represents the field variance due to chemical shift, which is different from the local 
susceptibility effect. The local magnetic field variance generated from susceptibility difference 
also depends on the geometry of the object, however, the chemical shift effect only depends on 
the material type [31].  
Phase aliasing  
Phase images are reconstructed from the complex signals acquired through the real and 
imaginary channels. The complex signal can be written as:  
ܵ ൌ 	ܵோ௘௔௟ ൅	 ݅	 ௜ܵ௠ ൌ 	 |ܵ| ∙ ܿ݋ݏ߮ ∙ ݔො ൅ |ܵ| ∙ ݏ݅݊߮ ∙ ݕො																																			ሺ2.26ሻ                         
which can also be written as:  
ܵ ൌ |ܵ| 	 ∙ ݁௜ఝሺ௥̅,௧ሻ																																																																ሺ2.27ሻ                         
 where |S| ൌ ටܵோ௘௔௟ଶ ൅ ௜ܵ௠ଶ  is the magnitude and φሺrറ, tሻ ൌ tanିଵሺ ௌ೔೘ௌೃ೐ೌ೗ሻ is the phase (as shown in 
Figure 2.4). 
However, as shown in Figure 2.4, phase values can only be correctly returned if they are between 
–π to π. If the phase value lies outside this interval, it will be wrapped back. For example, a 
phase of െ450° will wrap back to െ90°  This process is called phase aliasing. The true phase 
can be described as:  
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߶௧௨௥௘ሺݎറሻ ൌ ߶௠௘௔௦௨௥௘ௗሺݎറሻ ൅ 2ߨ ∙ ݊ሺݎറሻ																																																		ሺ2.28ሻ 
where ݊ሺݎറሻ are integers. In order to obtain the actual information about ∆ܤሺݎറሻ, ݊ሺݎറሻ needs to be 
determined to unwrap the measured phase.  
 
Figure 2.4: Complex representation of a signal vector S in the Real-Imaginary plane. |S| 
represents the magnitude and φ is the phase.  
Homodyne High Pass filter 
According to Eq. (2.25), since our interest for iron quantification is the field change due to tissue 
susceptibility, other terms relating to the global field inhomogeneity should be removed. Due to 
the fact that the background field is relatively low spatial frequency in nature, it can be removed 
by applying a high-pass filter. Homodyne high pass filter is a robust and efficient method for 
background removal, which is widely used in SWI [32]. 
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When doing the homodyne high-pass filtering, low-pass filtered k-space data is created first by 
applying a Hanning window to the central part of the k-space, and then reconstructing this low 
special frequency k-space data to the image domain (ρො୪୮). And then the original complex data (ρො) 
is divided by the low-pass filtered data to generate the complex high-pass filtered image (ρො୦୮). 
The pipeline of the homodyne high pass filter processing is shown in Figure 2.5 [29]. The high 
pass filtered phase image is generated by: 
߶௛௣ ൌ ܽݎ݃൫ߩො௛௣൯ ൌ ܽݎ݃	ሺߩො/ߩො௟௣ሻ																																																									ሺ2.29ሻ 
where the division is pixel-wised operation.  
The advantages of homodyne high pass filter include that no phase unwrapping is needed; it’s a 
very quick process, only about 10 seconds are need for processing a data set of 512×512×64; it’s 
robust; it provides good contrast and high SNR. However, the homodyne high pass filter also 
causes phase signal loss, especially for structures with relatively large sizes such as the globus 
pallidus, putamen, thalamus and so forth. This will lead to an underestimation of the tissue 
susceptibility which will further lead to errors for iron prediction [29].  
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Figure 2.5: The illustration of the step flow to do homodyne high pass filter [29].  
QSM reconstruction 
Induced magnetization ܯሬሬറ	creates dipolar field around it. The z-component of the field variation 
can be written as [29]:  
∆ܤ௭ሺ̅ݎሻ ൌ 	 ߤ଴4ߨ න݀
ଷ̅ݎᇱ ቊ3ܯ௭ሺ̅ݎ′ሻ 	 ∙ 	 ሺݖ̅ െ ݖ̅
ᇱሻଶ
|̅ݎ െ ̅ݎᇱ|ହ െ
ܯ௭ሺ̅ݎᇱሻ
|̅ݎ െ ̅ݎᇱ|ଷቋ
௩ᇱ
																									ሺ2.30ሻ 
which can be written as a convolution [29, 33]: 
∆ܤ௭ሺݎറሻ ൌ ߤ଴ܯ௭ሺݎറሻ ∗ ܩሺݎറሻ																																																								ሺ2.31ሻ 
where  ܩሺݎറሻ is the 3D Green’s function:  
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ܩሺݎറሻ ൌ 14ߨ ∙
3ܿ݋ݏଶߠ െ 	1
ݎଷ 																																																							ሺ2.32ሻ 
From Eq. (2.23) and (2.31), the following equation can be generated which is used to predict the 
induced magnetic field distribution from the magnetic susceptibility distribution:  
∆ܤ௭ሺݎറሻ ൌ ߤ଴ܯ௭ሺݎറሻ ∗ ܩሺݎറሻ ൎ ܤ଴߯ሺݎറሻ ∗ ܩሺݎറሻ																																															ሺ2.33ሻ 
The convolution can be expressed in the Fourier domain, and the field variations will become:  
∆ܤ௭ሺݎറሻ ൌ ܤ଴ ∙ ܨܶିଵሼܨܶሾ߯ሺݎറሻሿ ∙ ܨܶሾܩሺݎറሻሿሽ																																																ሺ2.34ሻ 
The Fourier transform of the Green’s function is:  
ܩ൫ሬ݇റ൯ ൌ ܨܶሾܩሺݎറሻሿ ൌ ቐ
1
3 െ
݇௭ଶ
݇௫ଶ ൅ ݇௬ଶ ൅ ݇௭ଶ 	,			ݓ݄݁݊	
ሬ݇റ ് 0													
0																					,			ݓ݄݁݊	ሬ݇റ ൌ 0
																								ሺ2.35ሻ 
Calculating the induced magnetic field distribution by the combination of Eq. (2.33), (2.34) and 
(2.35) is call “Forward Calculation”.  
Since ∆B୸ሺݎറሻ information can be extracted from phase images (φሺݎറሻ), χሺݎറሻ can be calculated 
from the inverse calculation (rearrange Eq. 2.34):   
߯ሺݎറሻ ൌ ி்షభൣீషభ൫௞ሬറ൯	∙	ఝ൫௞ሬറ൯൧ఊ	∙	஻బ	∙	்ா 																																																																				ሺ2.36ሻ   
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Figure 2.6 shows the general steps of creating QSM maps.  
 
Figure 2.6: Image processing procedures to generate susceptibility maps [29]. Phase unwrapping 
is not necessary for all the algorithms before background field removal. For example, when 
homodyne high pass filter is used to remove the background field, phase images don’t need to be 
unwrapped before applying the filter. Phase unwrapping can be done with or without brain 
binary mask images, but with the masks, the processing speed can be improved.  
As we can see in Eq. (2.36), ܩିଵ൫ሬ݇റ൯ goes to infinity when ܩ൫ሬ݇റ൯ is equal or close to zero, 
which leads to an ill-posed problem. This happens at the points on or near two conical surfaces in 
k-space at the magic angles of 54.7° and 125.3° from the B଴ direction [34]. This problem causes 
streaking artifact and high noise levels in QSM. This poor reconstruction behavior could be 
solved through either truncated k-space division [35, 36] or other optimization methods [29, 34, 
37].  
In this chapter, we have introduced the basic aspects of gradient echo imaging that relevant 
to susceptibility imaging, principles of phase imaging, phase image post processing and the link 
between the magnetic susceptibility and phase information. Iron is the most abundant and a 
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crucial metal element in human body [38]. It is a strong paramagnetic material. The presence of 
iron can influence the magnitude and phase signals. As a result, iron can be visualized and 
measured by MRI techniques. In the next chapter, we will review iron quantification methods.  
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Chapter Three    Brain iron and iron quantification 
        Iron is the most abundant metal element within the brain [38]. People are becoming more 
interested in understanding the roles of iron in brain normal functions and its association with 
neurodegenerative diseases. It has been known that iron is involved in a variety of processes 
which are vital for letting our brain function normally such as gene expression, neuronal 
development, enzymatic reactions, dopamine, heme, iron-sulfur cluster synthesis, electron 
transport and so forth [39]. Also, normal aging and the potential pathophysiology of many 
neurological disorders are thought to have correlation with excessive iron accumulation or iron 
deficiency [38]. For example, the iron elevation in the brain has been investigated extensively to 
understand its link to neurodegenerative diseases including Alzheimer’s disease [40], 
Parkinson’s disease [41], multiple sclerosis [18] and so forth. Iron deficiency has been reported 
to be associated with developmental delays [42], attention deficit hyperactivity disorder (ADHD) 
[43], restless legs syndrome [44] and neurodegeneration [45].  
Approximately, 3 to 5 grams of iron is stored in healthy people [46]. There are basically two 
categories of iron in the human body: heme iron which is in hemoglobin (two thirds of the total 
iron) and non-heme iron (one third) [8].  Transferrin, ferritin and hemosiderin are three important 
types of non-heme iron proteins. The function of transferrin is to carry iron from the blood to the 
whole body and brain tissues. It can bind two iron atoms and its molecular weight is 79.6 kg/mol. 
Ferritin is a soluble protein which stores excess iron atoms to maintain the homeostatic levels of 
iron. Ferritin has a large spherical protein coat. There can be up to 4500 iron atoms in a 24-unit 
ferritin molecule and the molecular weight is 474 kg/mol. Another form of iron storage protein is 
hemosiderin, which is water insoluble and is considered coming from denatured ferritin and 
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other material. It can be found in white blood cells and studies reported that relatively large 
amount of hemosiderin is present in diseased brains [47].  
3.1 Basic brain iron physiology 
Normal Iron transport in human brain 
Due to the presence of brain endothelium (blood-brain barrier or BBB), iron metabolism in 
the brain is separated from other parts of the body. Although the mechanism of how iron crosses 
BBB has not been completely understood, several pathways have been suggested. Those 
pathways include transferrin / transferrin receptor (Tf/TfR), lactoferrin receptor / lactoferrin 
(LfR/Lf) and GPI-anchored melanotransferrin / soluble melanotransferrin (MTf/sMTf) pathways 
[48]. A pathway for the transport of non-transferrin-bound iron across the BBB cells also exists 
[49]. Another suggestion is that ferroportin 1 (FP1)/hephaestin (Hp) and/or hephaestin-
independent (FP1/CP) iron export systems might also plays roles in Feଶା  transport across 
abluminal membrane of the BBB [48, 50].  
Iron induced oxidative stress 
Excessive iron deposition can be neurotoxic due to the possibility of generating induced free 
radicals which contribute to the oxidative reactions [51]. Brain cells consume oxygen to 
catabolize carbon- and hydrogen-rich molecules into energy. During this process, hydrogen 
peroxide (HଶOଶ) is formed. Hydrogen peroxide can go across cell membranes freely. When 
hydrogen peroxide reacts with ferrous (Feଶା), the famous Fenton reaction happens (Fenton, 
1893). The ferric (Feଷାሻ	iron and highly reactive hydroxyl radicals are formed [51].  
Feଶା ൅ HଶOଶ → Feଷା ൅ HOି ൅∙ OH 
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These free radicals (∙ HO) will interact with polyunsaturated fatty acid (RH) and take an electron 
from RH to produce another type of free radicals (R ∙). 
RH ൅∙ HO → R ∙ ൅HଶO 
The organic free radicals (R ∙) may also react with oxygen to form organic oxygen radicals 
(ROଶ ∙) 
R ∙ ൅Oଶ → ROଶ ∙ 
Then the oxygen radical will steal an electron from another lipid (RH) (it can be another 
biological molecule) to form an organic hydroperoxide (ROOH) and another free radical (R ∙), so 
the vicious cycle continues to damage the brain cells.  
ROଶ ∙ ൅RH → ROOH ൅ R ∙ 
The damage chain is lipid peroxidation which can destroy lipids. In brain, the cell 
membranes of neurons and many supporting cells are rich in polyunsaturated fatty acids, so they 
are easily damaged by lipid peroxidation and can even lead to cell death [51].  
Due to the high correlation of certain diseases with the problematic iron regulation, 
researchers have been motivated to find robust and efficient methods to quantify iron in vivo, 
which will provide better understanding of the normal iron behaviors and prognosis of disease 
related to iron deficiency and overload.  
 
27 
 
 
 
3.2 MRI methods for Iron quantification  
Since iron in the form of ferritin is strongly paramagnetic and there is sufficient amount of 
iron in the human brain, MRI signals (both magnitude and phase) can be related to iron 
concentrations. Using MRI, we can image iron in the form of ferritin, hemosiderin and 
deoxyhomoglobin. Moreover, tissue intrinsic parameters such as R2, R2*, magnetic 
susceptibility can be extracted from MR images for iron quantification. The motivation for 
quantifying iron is different for deoxhyhemoglobin, ferritin and hemosiderin. If we can quantify 
the levels of deoxyhemoglobin in veins, then we can estimate the oxygen saturation [35]. This is 
important in studying stroke, diseases with reduced perfusion such as multiple sclerosis (MS), 
and cerebral vascular reserve. Quantifying ferritin may play a role in diseases such as 
Parkinson’s disease, Huntington’s disease and a number of other diseases. Quantifying 
hemosiderin is important in studying microbleeds with a particular interest in stroke [52], 
dementia [53] and MS [54]. 
In this section, correlations between relaxation rates (R2, R2*, R2'), phase, magnetic 
susceptibility (QSM) and absolute iron content (both in vivo and ex vivo) will be summarized. In 
this thesis, the focus is on imaging iron in the form of ferritin.  
R2 method 
Local microscopic filed gradients (G) exist due to the presence of ferritin-loaded cells, 
which lead to the diffuse movement of hydrogen protons [55]. The signal loss from this kind of 
random movement won’t be recovered in spin echo sequence due to the stochastic nature of the 
Brownian motion [55]. As a result, R2 values are affected by diffusion changes contributed from 
iron [27]: 
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ܴ2௧௢௧௔௟ ൌ ܴ2଴ ൅ ܴ2ௗ௜௙௙																																																																	ሺ3.1ሻ 
where ܴ2଴ is the biological relaxation rate which is determined by proton density, field strength, 
temperature and so forth. ܴ2ௗ௜௙௙ is the relaxation from diffusion, which is defined as:  
ܴ2ௗ௜௙௙ ൌ ሺߛଶܩଶܦ/3ሻ ∙ ଶ																																																																	ሺ3.2ሻ 
where γ is the gyromagnetic ratio of proton, G is the local microscopic gradient, ܦ ൌ ߜଶ/ሺ2߬ௗሻ 
which is related to the average step parameters (a spin moves step size of δ every τୢ second). 
Since the presence of iron affects the local microscopic gradient G, therefore, iron effects can be 
seen in R2.   
R2 can be calculated by using multiple-echo spin echo sequence. Significant positive linear 
correlations between R2 values and iron concentrations have been revealed in several studies 
[55-58]. The correlation slopes reported by Langkammer et al and Mitsumori et al were 0.04 Hz 
per µg Fe/g wet tissue and 0.057 Hz per µg Fe/g wet tissue. In Langkammer et al’s study, a 3T 
magnet was used for scanning, and iron concentration was determined by inductively coupled 
plasma mass spectrometry (ICPMS). In Mitsumori et al’s study, a 4.7T magnet was used and in 
vivo iron concentration was estimated based on Hallgren & Sourander’s published iron-age 
equations [7]. However, all the previous R2 studies measured ܴ2௧௢௧௔௟ , which includes the 
confounding term (ܴ2଴) for iron quantification. Therefore, this technique had several limitations. 
First, because the diffusion effect from iron is subtle, ܴ2௧௢௧௔௟  is not sensitive enough for 
measuring iron content. Second, there are also several other factors could have impact on ܴ2௧௢௧௔௟ 
through ܴ2଴ such as water content, tissue composition, disease condition, formalin fixation [59] 
and so forth. Also, R2 varies in magnetic field strength. All of those disadvantages suggest R2 
correlates with iron content but it is not accurate enough to do iron quantification.  
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R2* and R2' methods  
R2* includes all the effects that can cause dephasing, which is defined as： 
ܴ2∗ ൌ ܴ2௧௢௧௔௟ ൅ ܴ2ᇱ																																																																							ሺ3.3ሻ    
R2′ is attributed to all the microscopic, mesoscopic and macroscopic scale field gradients that 
lead to static dephasing effects, which can be refocused in a spin echo sequence through the 180° 
rf pulse but not with a gradient echo sequence. For a spherical object embedded in a 
homogeneous tissue, R2′ can be written as [27]: 
ܴ2ᇱ ൌ 2ߨ9√3ߟߛ∆߯ܤ଴																																																																								ሺ3.4ሻ 
where ∆χ  is the magnetic susceptibility between the sphere and the background, B଴  is the 
uniform background magnetic field, η is the volume fraction. This equation shows the linear 
behavior of R2′ on both volume fraction and change in susceptibility. For cylindrical objects, R2′ 
is also related to the angle.  
The R2′ effect is much stronger than the iron induced diffusion effect embedded in R2. 
Therefore, both R2* and R2' are more sensitive to iron content than R2 [55, 60]. R2* maps can 
be generated from a multi-echo spoiled gradient echo sequence. R2* has been shown to be 
linearly correlated with iron concentration [55, 61, 62]. The previous published R2*-iron 
correlation slope is 0.27 Hz per µg Fe/g wet tissue according to an ex vivo study (3T, iron 
concentration was measured with ICPMS) [55], and 0.114 Hz per µg Fe/g wet tissue from an in 
vivo study (3T, iron content was estimated based on Hallgren & Sourander’s published iron-age 
equations). A study from Yao et al [62] revealed positive linear correlations between R2* and 
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iron concentration in three field strengths for both in vivo and in vitro data. The absolute R2* 
values and the R2*-iron correlation slopes are different in each field strength with the highest in 
7T and followed by 3T and 1.5T. They also showed that there is a nice correlation between iron 
with R2* change rate (with respect to field strength). However, the results found from in vivo 
and in vitro data were not consistent, which could be caused by formalin fixation. 
Although R2* is much more sensitive to iron changes than R2, it still suffers the same 
limitations as R2 because the baseline (ܴ2଴) term is also present in R2*. R2* is also affected by 
magnetic field strength and the object angle as discussed. ܴ2ᇱ	offers the advantage of not 
depending on ܴ2଴  to measure iron content. However, comparing ܴ2  with R2* to extract 
ܴ2ᇱaccurately is a difficult procedure and is prone to many errors [63, 64]. Another limitation of 
this technique comes from the signal loss due to the macroscopic susceptibility effects, which 
makes measuring R2* in the cerebral cortex and surrounding nasal sinuses difficult [65]. The 
artifacts due to susceptibility effects will be worse with long echo times and higher magnetic 
field strengths. Such artifacts can be reduced with a higher-order shimming and higher image 
resolution.  
Phase  
Another approach is using phase to estimate iron content [6, 66]. Phase values don’t depend 
on intrinsic relaxation parameters but directly relate to the local magnetic field variations which 
lead to the spatial distribution of the proton precession frequency.  
߮ ൌ ∆߱ ∙ ܶܧ ൌ െߛ ∙ ∆ܤሺݎറሻ ∙ ܶܧ																																																										ሺ3.5ሻ 
This method is very sensitive to small amounts of iron which induces changes of the magnetic 
susceptibility and hence should be more accurate than the noisy T2 and T2* methods.  
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However, other sources of phase shift also exist such as from magnetic field inhomogeneity 
at tissue-air interface and imperfect shimming [65].  These shifts are large enough to affect the 
entire phase image and have to be filtered. In addition, phase values can only be returned 
correctly if it’s between –π to π, any degree beyond the range will be wrapped back to this range. 
Thus, a proper algorithm is a critical step for phase processing. Moreover, another challenging 
fact of using phase as an indicator of iron concentration is that besides the object susceptibility, 
phase also depends on the geometry and orientation of the object [62]. As a result, it is more 
difficult to localize and quantify iron deposition independent of geometry. 
Quantitative susceptibility mapping (QSM) 
QSM is the most modern MRI approach for estimating iron content. The QSM maps are 
generated by using an inversion process on the phase images. The details of the theory and 
processing steps have been introduced in Chapter 2.2. In theory, QSM approach is independent 
of field strength, echo time, the relative orientation and the shape of the object [67]. The 
correlations between susceptibility value and iron concentration have been summarized in Zheng 
et al’s recent published paper [67] (Table 3.1). Other than the correlation slopes listed in Table 
3.1, Lim et al just published a slope (0.73 ppb/µg iron/g wet tissue) for their new in vivo study. 
However, the published in vivo susceptibility-iron correlations were determined from very 
limited samples. And the way they quoted iron concentrations from the postmortem study [7] 
were also questionable. The detailed discussion about this can be referred to Chapter 5.   
Other MRI methods 
The most popular ways of measuring iron with MRI have been reviewed. There are still some 
other methods proposed to assess iron accumulation such as magnetic field correlation (MFC) 
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[68] and direct saturation imaging (DSI) [69]. However, these are beyond the scope of this thesis, 
so the details of those methods won’t be addressed here.  
In the next chapter, a specific study of measuring putative iron using phase and ∆R2∗ in healthy 
people will be presented. 
  
 
 
 
 
Table 3.1: Correlation between susceptibility mapping and iron concentration [67].  
Authors Correlation slope * Structures 
Background 
removal QSM method 
Myelin 
correction 
Field  
(Tesla) Sample Iron 
Zheng et al. 
(2013) 1.28~1.33 N.A. Quadratic fitting 
Forward 
fitting N.A. 3T Ferritin ICPMS 
Zheng et al. 
(2013) 0.83 GP,PUT,CN SHARP TKD (SO) No 3T 
Cadaver 
brain XRF 
Haacke. (2012) 0.59 GP,PUT,CN SHARP TKD (SO) No 3T In vivo brains H&S 
Shmueli et al. 
(2009) 0.56 PUT,RN, SN 
Polynomial 
fitting TKD (SO) No 7T 
In vivo 
brain 
H&S 
** 
Wharton et al. 
(2010) 0.75/0.6 
GP,SN, 
RN,PUT,CN,TH,GM 
Simulated 
geometric 
effect+fitting 
TKD 
(MO/TSO) No 7T 
In vivo 
brains H&S 
Langkammer et 
al. (2012) 0.89 GP,PUT, CN, TH SHARP HEIDI (SO) No 3T 
Non-fixed 
Cadaver 
brains 
ICPMS 
Schweser et al. 
(2011) 1.30 
GP, SN, DN,PUT, CN, 
TH, WM,GM SHARP 
MO 
regularization Yes 3T 
In vivo 
brains H&S 
Schenck (1992) 
1.32 (1.27*) 
 
N.A. N.A. N.A. N.A. N.A. N.A. N.A. 
*The unit of the slope is 1ppb/µgFe /g wet tissue (=1.04g/ml at 36.5 ºC) for wet tissue; the unit for the ferritin solution is 1 
ppb/µgFe/ml and the corresponding theoretical value is 1.27 ppb/ µgFe/ml. 
**H&S: (Hallgren and Sourander, 1958); SO: single orientation; MO: multiple orientation; TKD: thresholded k-space division. 
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Chapter Four    Correlation of putative iron content as represented by changes 
in phase and R2* with age in deep gray matter nuclei of healthy adults 
Introduction 
In this chapter, both phase and ∆R2∗methods for measuring iron in the brain will be considered. We 
will specifically discuss the concept of two-region analysis where a given area of the brain is 
broken up into low and high iron content areas. In the later section of this chapter, an application of 
this iron quantification method is presented for normal controls. 
Iron has long been recognized to play a key role in brain function such as oxygen transport, 
neurotransmitter synthesis, electron transfer, and myelin production [1, 2]. Despite the positive 
implications when in a free ferrous form, iron is known to be toxic and lead to free radical 
production. Recently, there has been a renewed interest in the role of iron in neurodegenerative 
diseases such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease and other conditions 
including aging [1, 2, 47, 70, 71]. Due to the importance of iron in the human body, any iron 
misregulation can be a major factor and can be used as a marker for neuronal death and other 
pathological evidence in neurodegenerative diseases [72]. For instance, the disturbance of iron 
metabolism can occur at several levels: iron uptake and release, storage, intracellular metabolism, 
and regulation. However, the body has a number of ways to deal with this issue by storing excess 
iron in the form of ferritin or hemosiderin. Ferritin appears to be the normal form of iron storage 
while hemosiderin often appears when there has been bleeding and macrophages, and this fact can 
be used to help consolidate the iron form [70, 73, 74]. 
Using methods such as diaminobenzidine acid enhanced Perl’s staining has revealed iron in many 
cell types of the central nervous system, such as neurons, microglia, oligodendroglia, astrocytes and 
in some myelin sheaths [75]. Iron is also found to be of higher concentration in gray matter (GM) 
than in white matter (WM) [76]. Deep gray matter structures accumulate ferritin at different rates at 
different ages [7, 75, 77]. It is believed and often quoted [7] that iron deposition increases quickly 
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with age and then levels off or increases more slowly. Furthermore, it has been shown that there are 
major iron deposits in the form of ferritin associated with the basal ganglia [78, 79]. The interest in 
iron has led to attempts to quantify iron in vivo in neurodegenerative diseases in order to understand 
their pathogenesis, monitor their progress and determine neuroprotective treatments. 
 
Iron Quantification: previous approaches and SWI 
A variety of methods have been proposed attempting to measure iron with magnetic resonance 
imaging (MRI), including: T2, T2*, T2' [60, 80], field dependent relaxation rate increase (FDRI) 
[81, 82], magnetic field correlation (MFC) [65] and susceptibility weighted imaging (SWI) [8]. 
Although R2 (or 1/T2) related methods using a spin echo sequence have been shown to be more 
sensitive to GM/WM differentiation than R2', it has not been able to show clear specificity for iron 
[80] in diseases such as Parkinsons because of confounding issues such as variable water content. 
On the other hand, R2' has been shown to yield a good correlation with iron load, as R2' was seen 
to increase for higher iron content structures. Individual T2 relaxation times showed more variation 
after 45 years of age [83]. In R2' and R2* methods, R2' and R2* increased in GM but decreased in 
WM as a function of age [84].  
Recently, SWI [32, 85] has been used to measure or at least infer iron content in brain parenchyma 
[8, 32, 86]. A recent comparison study between SWI and others sequences [12] confirmed that SWI 
can be used as a tool to quantify iron deposition in the brain. Other studies [66, 87] have also tried 
to probe brain iron with SWI by investigating the pattern of mineralization in the deep gray matter 
as a function of age. To date, many researchers have looked at total iron content in specific regions 
of the brain such as basal ganglia and thalamus, but no one has yet focused on establishing either 
the regional changes of high iron content or how much iron content in this specific region changes 
as a function of age. 
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Iron quantification using gradient echo-based SWI data 
In the following discussion, we focus on introducing the basic elements of iron quantification using 
SWI in seven deep grey matter nuclei: caudate nucleus (CN), globus pallidus (GP), putamen (PUT), 
pulvinar thalamus (PT), substantia nigra (SN), red nucleus (RN), and thalamus (THA). The regions 
of interest (ROIs) are outlined manually based on their anatomical locations and the boundaries 
shown in the high-pass filtered SWI phase images (Figure 4.1). These structures are measured 
bilaterally.  
 
 
Figure 4.1: Example boundaries are shown for: A) caudate nucleus, B) globus pallidus (black 
arrow) and putamen (white arrow), C) red nucleus (black arrow) and substantia nigra (white arrow); 
D) pulvinar thalamus, and E) thalamus. 
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Drawing the ROIs:  
One or more slices can be selected for analysis accordingly. The selected slices should show a well-
defined border for the structures of interest. As a further condition, slices severely affected by sinus 
artifacts cannot be used. The bright boundaries outside the structures are also avoided because this 
large positive phase shift is most likely associated with the iron-induced dipolar field patterns in the 
tissue [88]. Checking the boundary in adjacent slices is also necessary for making sure that the 
traced boundary is right. If a single slice analysis is sufficient, then the selected slice should show 
the largest area and agree with the above requirements.  
Structures are zoomed by a factor of four to make the boundaries easier to determine and avoid the 
iron-induced dipolar field. ROIs are drawn first on the phase images and then copied to the 
magnitude images, this guarantees that the boundaries are exactly the same in both magnitude and 
SWI filtered phase images. 
Here are some criteria for slice selection of different structures if just a single slice is chosen for 
analyzing each structure. Separate slices are chosen for the CN, the GP and the PUT respectively. 
The slice for the PT is chosen to have the highest contrast on the phase images and to avoid the SN 
or RN structures and the major veins. The RN and SN are drawn on the same slice that shows the 
ring-like hyperintensity signal outside the RN , and shows no fusion of the SN and RN. For the 
thalamus, the slice that clearly shows the boundary without showing the RN or subthalamic nucleus 
is selected. Also, the internal capsule needs to be avoided while drawing the ROI around the 
thalamus. Boundaries drawn for these structures are shown in Figure 4.1.  
 
Phase units and SWI processing using SPIN  
The ability to quote iron, say, in micrograms of iron per gram tissue (μg Fe/g tissue), depends on 
associating a given phase value (preferably in radians) with an amount of iron. Each manufacturer 
stores phase values in different ranges and even the same manufacturer can use different phase 
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units from one version of software to another. For example, General Electric (GE) uses the range -
3142 to 3142 to represent –π to π radians. One the other hand, Siemens Phase Unit (SPU) is the 
scale used in Siemens MR Systems to represent phase information of the MR signal. This scale 
ranges from 0 to 4096 which is equivalent to –π to π in radians.  
For a right-handed system, 0 corresponds to –π, 2048 corresponds to 0, and 4096 corresponds to π. 
On the other hand, for a left-handed system, 0 is π and 4096 is –π. If the scanner uses SPU, 
observers need to know whether the scanner uses right or left hand system. One easy way to judge 
which system the scanner uses is to check the veins and grey matter in the phase images (without 
inversing). If they are hypo-intense (appear dark), then it is a right-handed system, whereas if they 
appear hyperintense (bright), it is a left-handed system. In principle, in order to compare with other 
systems, one should always convert the phase values into radians. (Another versions of Siemens 
software is now using -4096 to 4096 and similar transformations must be considered to properly 
record the phase in radians instead of these arbitrary units.) 
After getting the magnitude and unfiltered phase images, SWI processing is done using SPIN 
(Signal Processing in NMR, Detroit, MI, USA). The function is under Process>MIP/SWI 
Processing>MIP with Phase Multiplications (SWI processing). Following the diagram, two sets of 
images will be obtained: the high pass filtered phase images (HP) and the Minimum Intensity 
Projection (MinIP) images. When the images are from a left-handed system, “positive” needs to be 
selected, whereas if the images are from a right-handed system, choose “negative”. The high pass 
filter is used to remove the low-spatial-frequency inhomogeneities caused by background fields and 
air/tissue interfaces [89]. People usually use 64×64 or 32×32 as the filter size because these have 
minimal effects on contrast for most small structures [1, 2, 90]. To obtain the MinIP images, a 
phase mask f(x) is generated from the filtered phase image and used to create the fusion image, 
SWI(x), by multiplying the magnitude image ρ(x) by the phase mask four times, that is: SWI(x) = 
ρ(x)f4(x) [31].  
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Two-region analysis:  
Each structure can be seperated into two regions which contains high iron and low iron using 
appropriate thresholds.  The reason we analyze both a low iron content region (RI) and a high iron 
content region (RII) is that an entire ROI analysis may reduce the sensitivity to more subtle changes 
in iron content (Figure 4.2). The images are usually zoomed by a factor of 4 in the areas of interest 
before starting preforming the two region analysis. To automatically separate these two regions, 
thresholds related to phase for different structures are used according to literature [90]. The 
thresholds are set using the measured mean value minus two times the standard deviation across an 
elderly population (age range 55 to 85 years) to be on the conservative side as outlined in a study 
by Haacke et al [90]. For pulvinar thalamus and thalamus which were not included in these papers, 
we analyzed twenty normal cases which were randomly chosen from the subjects to get the mean 
value and standard deviation. These phase thresholds mentioned above are from a right-handed 
system data. For left-handed system data, the thresholds need to be adjusted by subtracting from 
4096 SPU. Threshold values are shown in Table 4.1.  
 
Figure 4.2: An example of a two-ROI analysis in the caudate nucleus. The low iron region is 
denoted as RI and the high iron region as RII. The thalamostriate region is shown in A) and again 
in B) with the smaller region being the high iron content region and the larger region being the total 
region (RI + RII). The mean of the total region is 1989 SFU, while mean of RII is 1741 SFU. This 
data is from a normal healthy volunteer. 
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Table 4.1: Threshold values for the regional separation 
 CN GP PUT PT SN RN THA 
Phase (rad, left-handed system) 0.190a 0.172a 0.330a 0.143b 0.356a 0.261a 0.049b 
Phase (SPU) (left hand system) 2172a 2160a 2263a 2141b 2280a 2218a 2080b 
Phase (SPU) (right hand system) 1924a 1936a 1833a 1955b 1816a 1878a 2016b 
Magnitude (arbitrary unit) 117b 84b 112b 126b 90b 101b 118b 
PUT: Putamen.    CN: Caudate Nucleus.   GP: Globus Pallidus.   RN: Red Nucleus.   PT: Pulvinar 
Thalamus.   SN: Substantia Nigra.   THA: Thalamus.  
a Determined from [90]    
b Determined from 20 normal cases randomly selected from the sample 
SPU = Siemens phase unit 
rad = radian 
 
 
For a right handed system, phase is given by  
φ ൌ െγ ∙ ∆B ∙ TE																																																									ሺ4.1ሻ 
The choice of echo time is usually determined based on setting the phase of a vein parallel to the 
main field being π [32]. This yields an echo time of 50ms at 1.5T for a hematocrit of 0.45 while 
practically, to avoid aliasing, a slightly shorter echo time is chosen, typically 40ms. This value also 
leads to a good R2* effect and phase effect for vessels perpendicular to the main field. Similarly, 
20ms TE is used at 3T and 15ms at 4T and so forth, keeping the expected phase for a given 
susceptibility constant as the field strength increases. In this case, B0TE is always 60T ∙ ms and the 
phase images will look the same, except for the SNR of course. When the data are not collected 
using such TEs, a factor (κ) can be used to “correct” either the measured phase or the thresholds 
where 
  κ = (40/TE)(1.5/ B0)                             (4.2) 
As an example, consider a set of images collected at 1.5T with an echo time of 20ms instead of 
40ms. In order to use the thresholds described above, one has to multiply the phase differences by a 
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factor of κ = (40/TE)(1.5/ B0) = (40/20)(1.5/1.5) = 2. On the other hand, for the regional analysis, 
one can also simply divide the threshold values by 2. An important point to remember is that after 
high pass filtering, the phase of the white matter often has near zero value (or around 2048 in SPU). 
This is because the WM dominates the low spatial frequency component of the image. To measure 
the amount of iron, one measures the phase change between the white matter and the region of 
interest or between the CSF and the region of interest. Although the latter is preferred since CSF 
contains no iron, we used WM as the baseline because it is generally easier to measure and usually 
appears as zero phase after filtering.  
The conversion of phase from SPU to radian is (φ-2048)π/2048. The phase unit is also possible to 
be converted to parts per million (ppm) field deviation via δ = Δφ/(5.09π) [90]. To convert from 
SPU to µg Fe/g tissue, one can use  
C୊ୣ ൌ ∆߮/180 ൈ 60ߤ݃/ܿܿ ൈ ݌݅ݔ݈݁	݊ݑܾ݉݁ݎ ൈ ݌݅ݔ݈݁	ݒ݋݈ݑ݉݁													ሺ4.3ሻ 
Eq. (4.3) is derived by taking 180 SPU as equivalent to the effect of 60 μg Fe/g tissue [90]. 
However, based on the results on ΔR2* changes, it is suggested that a phase change of 180 SPU 
(0.276 rad) could represent as much as 240 μg Fe/g fresh tissue. If this number is used, and we 
assume a density of 1g/cm3 for tissue, then the total iron would be calculated as follows: 
C୊ୣ ൌ ∆߮/180 ൈ 240ߤ݃/ܿܿ ൈ ݌݅ݔ݈݁	݊ݑܾ݉݁ݎ ൈ ݌݅ݔ݈݁	ݒ݋݈ݑ݉݁												ሺ4.4ሻ 
In later part of this chapter, we will be showing iron content density expressed in four different 
units for PUT, PT and SN (Figures 4.14 to 4.16).  
 
∆R2* and iron content 
The magnitude differences are related directly to iron via changes in R2* or ΔR2* [80, 84, 91]. If a 
multi-echo SWI sequence is used, R2* could be calculated by taking the ratio of the magnitude 
signal from two echoes to give:  
ܵଶ
ଵܵ
ൌ ݁ି∆்ா∙ோଶ∗																																																						ሺ4.5ሻ 
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We can find R2* that is proportional to the change of iron content from 
    )(*2)ln(1
1
2 FeR
S
S
TE
                                (4.6)                    
Since only a single echo data set was collected (as has been the case here), by taking the average 
magnitude signals of 10 patients with the lowest iron content as the baseline magnitude value (S0), 
the iron content change relative to the lowest iron content patients can be calculated through the 
ratio of the individual’s magnitude signal to the baseline magnitude, which yields: 
ଵܵ
ܵ଴ ൌ ݁
ି்ா∙∆ோଶ∗																																																													ሺ4.7ሻ 
where S1 is the signal from a given patient at any age and S0 is the baseline signal. Again, we can 
find ΔR2* that is proportional to the change of iron content from 
െ 1TE ln ൬
ଵܵ
ܵ଴൰ ൌ ∆ܴ2
∗ሺܨ݁ሻ																																															ሺ4.8ሻ 
For the iron content predicted from magnitude signals, we suggest using 67/s for R2* or a 
corresponding ΔR2* of 1mg Fe/g tissue [8]. 
 
Iron quantification: R2* versus Phase 
As discussed in the introduction, both R2* and phase have been used to study iron in the brain [66]. 
Several studies where these two approaches (T2* and phase methods) were used showed good 
agreement in some structures, but not such good agreement in other structures [60, 80, 92]. Which 
approach is better likely depends on the amount of iron present and possibly some further 
complications related to the mechanism of signal loss in T2* and the generation of phase for 
microscopic structures. The manifestation of each is really quite different.  
For large amounts of iron where strong dephasing across a voxel occur, changes in iron content will 
cause signal loss and therefore a reduction in T2*. However, for smaller amounts of iron where 
phase dephasing effects across a voxel are small, there may be little noticeable effect on T2* even 
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in the presence of what could be physiologically a dangerously high level of iron. On the other 
hand, phase is known to be very sensitive to subtle changes in magnetic field or frequency shift and 
therefore is much more sensitive to iron in smaller concentrations. As the amount of iron increases, 
phase and magnitude information start to correlate more strongly showing an almost linear 
correlation. However, when the iron content is too large, phase aliasing occurs and the linear 
correlation with phase may disappear. This problem may be avoidable by using a multi-echo SWI 
sequence in the future and using the short echo data to unwrap the long echo data. From this 
discussion, the following conclusion can be drawn: T2* underestimates iron content when the 
amount of iron is small, whereas phase underestimates iron content if iron content is too high 
(Figure 4.3). 
 
Figure 4.3: A plot of phase iron versus magnitude iron for a series of 100 normal subjects. The 
correlation is best when larger amount of iron is present. The values are plotted for Putamen in both 
left and right hemispheres.  
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Establishing a baseline for normal brain iron content as a function of age 
To study iron as a function of age using SWI filtered phase and magnitude images, 100 healthy 
adults (20-69 years; mean = 43 years) were evaluated using a single gradient echo SWI sequence. 
The original magnitude and high pass filtered phase data (high pass filtered with a 64x64 
homodyne filter) were used to evaluate iron content in the SN, RN, GP, PUT, CN, THA and PT. 
Each structure was broken into two parts: a high iron content region and a low iron content region. 
For all structures except the GP, we found an increase in putative iron content with age both for the 
total region and for the high iron content region (Figure 4.4 - 4.12). In some cases, the rate of iron 
deposition increased after the age of 40 years as evidenced in Figure 4.13 and Tables 4.2 and Table 
4.3. In the figures that follow, we consider first the different measures of iron that were made: the 
putative iron in the high iron content region, the average iron per voxel in the high iron content 
region, the normalized area of the high iron content region, and the average iron (iron density) in 
the total region. Figure 4.4 shows all four of these iron measures for both ∆R2∗	and phase for one 
structure that best delineates the iron behavior in the putamen. Figures 4.5 and 4.6 show the 
putative iron in the high iron content region for both magnitude and phase for the rest of the 
structures. Figures 4.7 and 4.8 show the putative iron in the whole region for both magnitude and 
phase. Figures 4.9 and 4.10 show the average iron in the total structure for both magnitude and 
phase. Figures 4.11 and 4.12 show the normalized area of high iron content region as a function of 
age for both magnitude and phase. The normalized percent area of high iron content region relative 
to the total area was used to avoid the influence by the size change for a single structure between 
individuals. Quantitative results for iron as a function of age for all the structures in terms of the 
above eight measures are shown in Table 4.2.  
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Figure 4.4: Putative iron measurement results as a function of age in Putamen. An increase in iron 
content - represented here by the increase in phase and ΔR2* - with age for total iron, average iron 
and the iron area are seen in the PUT. Stars and dashdot line are the values and fit of the right 
hemisphere. Triangles and solid line are the values and fit of the left hemisphere. r2 is the 
coefficient of determination. r2 is larger for the quadratic fit than just linear fit. L stands for the left 
hemisphere. R stands for the right hemisphere.  Quadratic relationships can be found in plots a, b, e, 
and f representing the total iron in RII predicted from phase (a) and magnitude (b) and the area in 
high iron region (phase (e) and magnitude (f)). This effect is not seen in the total region iron for the 
whole structure (c, d, g, and h).  
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Figure 4.5: Putative iron content - represented here by ݌݄ܽݏ݁ ൈ ݒ݋݈ݑ݉݁	and ∆ܴ2∗ ൈ ݒ݋݈ݑ݉݁ - in 
high iron content region in CN, PT, and THA where iron is seen to increase with age. Iron in CN 
and PT shows quadratic relationship with age. Stars and dashdot line are the values and fit of the 
right hemisphere. Triangles and solid line are the values and fit of the left hemisphere. r2 is the 
coefficient of determination. L stands for the left hemisphere. R stands for the right hemisphere. 
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Figure 4.6: Putative iron content - represented here by ݌݄ܽݏ݁ ൈ ݒ݋݈ݑ݉݁	and ∆ܴ2∗ ൈ ݒ݋݈ݑ݉݁ -  in 
high iron content region in RN, SN, and GP. In all these structures, a significant increase with age 
is seen. For GP, iron predicted from magnitude shows quadratic relationship with age. Stars and 
dashdot line are the values and fit of the right hemisphere. Triangles and solid line are the values 
and fit of the left hemisphere. r2 is the coefficient of determination. L stands for the left hemisphere. 
R stands for the right hemisphere. 
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Figure 4.7: Putative iron content - represented here by ݌݄ܽݏ݁ ൈ ݒ݋݈ݑ݉݁	and ∆ܴ2∗ ൈ ݒ݋݈ݑ݉݁ -  in 
the whole region in CN, PT, and THA where iron is seen to increase with age. Putative iron in CN, 
PT, and THA shows linear relationship with age. Stars and dash-dot line are the values and fit of 
the right hemisphere. Triangles and solid line are the values and fit of the left hemisphere. r2 is the 
coefficient of determination. L stands for the left hemisphere. R stands for the right hemisphere. 
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Figure 4.8: Putative iron content - represented here by ݌݄ܽݏ݁ ൈ ݒ݋݈ݑ݉݁	and ∆ܴ2∗ ൈ ݒ݋݈ݑ݉݁ -  in 
the whole region in RN, SN, and GP where iron is seen to increase with age except that in GP 
represented by phase. Putative iron in RN, SN, and GP shows linear relationship with age. Stars 
and dash-dot line are the values and fit of the right hemisphere. Triangles and solid line are the 
values and fit of the left hemisphere. r2 is the coefficient of determination. L stands for the left 
hemisphere. R stands for the right hemisphere. 
50 
 
 
 
 
Figure 4.9: Average iron - represented here by average phase and ΔR2* -  of the whole structure 
as a function of age in CN, PT and THA. Stars and dash-dot line are the values and fit of the right 
hemisphere. Triangles and solid line are the values and fit of the left hemisphere. r2 is the 
coefficient of determination. L stands for the left hemisphere. R stands for the right hemisphere. 
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Figure 4.10: Average iron - represented here by average phase and ΔR2* - of the whole structure 
as a function of age in RN, SN and GP. Stars and dash-dot line are the values and fit of the right 
hemisphere. Triangles and solid line are the values and fit of the left hemisphere. r2 is the 
coefficient of determination. L stands for the left hemisphere. R stands for the right hemisphere.   
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Figure 4.11. Normalized area of high iron content region as a function of age in CN, PT, and THA. 
High iron content area in CN and PT show strong quadratic relationship with age (increase). Stars 
and dashdot line are the values and fit of the right hemisphere. Triangles and solid line are the 
values and fit of the left hemisphere. r2 is the coefficient of determination. L stands for the left 
hemisphere. R stands for the right hemisphere. 
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Figure 4.12: Normalized area of high iron content region as a function of age in RN, SN and 
GP. High iron content area in RN shows significant linear relationship with age. Stars and dashdot 
line are the values and fit of the right hemisphere. Triangles and solid line are the values and fit of 
the left hemisphere. r2 is the coefficient of determination. L stands for the left hemisphere. R stands 
for the right hemisphere. 
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Table 4.2: Slopes of phase and magnitude iron measures as a function of age in the two hemispheres 
 Age(yr.) Iron-Phase-RII (rad×mm3/yr.)  Iron-Phase-Total (rad×mm3/yr.)  Average iron-Phase-Total (10-3 rad/yr.)  Average iron-Phase-RII (10-3 rad/yr.)    
  Slope  Slope  Slope  Slope   Left Right Total Left Right Total Left Right Total Left Right Total 
PUT 20-39 0.16±0.08 0.27±0.11 0.21±0.07  2.24±0.81 2.3±0.84 2.27±0.58  2.03±0.63 2.03±0.65 2.03±0.45  0.14±0.93 0.84±1.43 0.49±0.85 40-69 2.07±0.52 2.21±0.63 2.14±0.41  2.80±0.76 3.00±0.82 2.90±0.56  2.65±0.67 2.60±0.67 2.63±0.47  2.63±0.67 2.65±0.75 2.64±0.50 
CN 20-39 0.79±0.32 0.64±0.34 0.71±0.23  0.85±0.52 0.38±0.53 0.62±0.37  1.27±0.73 0.79±0.78 1.03±0.53  0.85±0.53 0.42±0.40 0.64±0.33 40-69 2.00±0.33 1.35±0.29 1.68±0.22 1.72±0.37 1.19±0.37 1.46±0.27 2.37±0.50 1.77±0.54 2.07±0.37 1.92±0.41 1.56±0.51 1.74±0.33
GP 20-39 -0.21±0.66 -0.03±0.64 -0.12±0.45  -0.20±0.75 -0.38±0.68 -0.29±0.50  -0.07±0.69 -0.24±0.61 -0.16±0.46  -0.29±0.94 0.35±0.71 0.03±0.59 40-69 1.16±0.91 1.03±0.86 1.10±0.62  0.36±0.68 0.08±0.62 0.22±0.46  -0.14±0.68 -0.10±0.61 -0.12±0.46  1.89±1.57 2.88±1.60 2.39±1.11 
RN 20-69 0.25±0.03 0.19±0.03 0.22±0.02  0.55±0.07 0.56±0.07 0.56±0.05  2.23±0.34 2.19±0.33 2.21±0.24  0.97±0.18 0.84±0.16 0.91±0.12 
PT 20-69 0.30±0.06 0.36±0.06 0.33±0.04  0.31±0.08 0.32±0.08 0.31±0.08  1.02±0.21 1.09±0.22 1.10±0.15  0.51±0.09 0.55±0.09 0.53±0.07 
SN 20-69 0.10±0.06 0.12±0.06 0.11±0.04 0.19±0.12 0.20±0.12 0.19±0.08 1.50±0.39 1.43±0.37 1.46±0.27 0.31±0.21 0.52±0.21 0.41±0.15
THA 20-69 0.78±0.19 0.65±0.19 0.72±0.13  0.67±0.28 0.70±0.27 0.69±0.19  0.34±0.13 0.35±0.13 0.34±0.09  0.62±0.08 0.50±0.08 0.56±0.06 
 
 Age(yr.) Iron-Magnitude-RII (sec
-
1×mm3/yr.) 
 Iron-Magnitude-Total (sec-1×mm3/yr.)  Average iron-Magnitude-Total  (10-3ms-1/yr.) 
 Area-Phase-RII (10-3 %/yr.)    
  Slope  Slope  Slope  Slope   Left Right Total  Left Right Total Left Right Total Left Right Total 
PUT 20-39 0.06±0.02 0.06±0.02 0.06±0.01  0.11±0.04 0.13±0.04 0.12±0.03  0.10±0.03 0.10±0.03 0.10±0.02  0.33±0.17 0.56±0.22 0.45±0.14 40-69 0.21±0.05 0.19±0.05 0.20±0.04  0.14±0.04 0.16±0.05 0.15±0.03  0.15±0.04 0.14±0.04 0.14±0.03  3.97±1.01 3.76±1.29 3.87±0.84 
CN 20-39 0.04±0.01 0.02±0.01 0.03±0.01  0.06±0.02 0.03±0.02 0.04±0.02  0.07±0.03 0.06±0.03 0.06±0.02  4.21±1.72 3.51±1.95 3.86±1.28 40-69 0.11±0.03 0.08±0.03 0.10±0.02  0.09±0.02 0.07±0.02 0.08±0.02  0.12±0.02 0.09±0.03 0.10±0.02  8.75±1.50 6.01±1.48 7.38±1.06 
GP 20-39 0.02±0.02 0.02±0.02 0.02±0.01  0.07±0.06 0.06±0.05 0.07±0.04  0.07±0.05 0.07±0.04 0.07±0.03  -0.75±2.06 -0.45±1.90 -0.6±1.39 40-69 0.13±0.06 0.10±0.05 0.11±0.04  0.10±0.05 0.07±0.05 0.09±0.04  0.07±0.05 0.07±0.05 0.07±0.03  -0.03±1.50 -0.65±1.38 -0.34±1.01 
RN 20-69 0.03±0.00 0.03±0.00 0.03±0.00  0.03±0.01 0.02±0.00 0.02±0.00  0.13±0.01 0.12±0.01 0.13±0.01  3.02±0.52 2.14±0.44 2.58±0.34 
PT 20-69 0.03±0.00 0.03±0.00 0.03±0.00  0.02±0.00 0.02±0.00 0.02±0.00  0.07±0.01 0.08±0.01 0.08±0.01  4.40±0.80 5.64±0.85 5.02±0.59 
SN 20-69 0.02±0.00 0.01±0.00 0.02±0.00  0.02±0.01 0.02±0.00 0.02±0.00  0.07±0.01 0.07±0.01 0.07±0.01  0.71±0.42 0.76±0.42 0.73±0.30 
THA 20-69 0.06±0.01 0.06±0.01 0.06±0.01  0.10±0.02 0.10±0.01 0.10±0.01  0.05±0.01 0.05±0.01 0.05±0.00  1.92±0.72 1.72±0.71 1.82±0.50 
PUT: Putamen.    CN: Caudate Nucleus.   GP: Globus Pallidus.   RN: Red Nucleus.   PT: Pulvinar Thalamus.   SN: Substantia Nigra.   THA: Thalamus 
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For PUT, CN, PT, and GP, the measures related to the high iron content region showed an 
impressive quadratic relation with age (Figure 4.4a, 4.4b, 4.4e, 4.4f, 4.5a, 4.5b, 4.5d, 4.6f). 
Generally, the results seemed to be fairly flat in the first two decades (20–40 years), but the local 
iron content dramatically increased after 40 years of age. Increases occurred not only in the area of 
the iron deposition but also in the average iron content. Fitting the data to two separate curves for 
20–40 years old and 40–70 years old shows more clearly the dichotomous iron behavior in these 
two age ranges (Figure 4.13). This rapid growth of iron build-up is not easily seen in the whole 
structure iron analysis where only a linear relationship with age is seen (Figure 4.4g and h and 
Figures 4.7–4.10). 
The resultant iron deposition level changes depending on whether one examines the average iron 
deposition in the whole structure, iron in the high iron content region (RII), or average iron in RII. 
The order of the structures from the highest (scales as 1) to lowest (scale as 7) is shown in Table 
4.3. All these changes may tell us something new and different about the iron deposition in each 
structure. Comparing structures for both hemispheres, we found some phase- and magnitude related 
measures of iron content showing significant differences between the two hemispheres. Most of the 
time, the left hemisphere contains more iron than the right hemisphere (Tables 4.4 and 4.5). 
Statistically, the PUT, CN, GP, and RN showed the largest effect. In addition, from Table 4.2, it 
appears that the slope of the linear fit of these measurements in the left hemisphere was always 
higher than that in the right hemisphere, except for the PT and the SN. 
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Figure 4.13: Putative iron content in two age intervals - younger and older than 40 years old 
subjects - giving a clear idea about iron deposition changes. Stars and dashdot line are the values 
and fit of the right hemisphere. Triangles and solid line are the values and fit of the left hemisphere. 
r2 is the coefficient of determination. L stands for the left hemisphere. R stands for the right 
hemisphere. 
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Table 4.3: The orders of high to low iron deposition over time. 
  PUT RN CN PT SN GP THA 
Phase Average iron (whole structure) 1 2 3 4 5 6 7 
 Iron in RII 1 6 2 5 7 3 4 
 Average iron in RII 1 4 3 6 7 2 5 
Magnitude Average iron (whole structure) 1 2 3 4 5 6 7 
 Iron in RII 1 5 3 5 6 2 4 
 Average iron in RII 3 2 4 5 6 1 7 
 
Comparison between this study with some other studies 
It is well known that iron deposition in the brain increases with age [7, 8, 66, 76, 93]. The work by 
Hallgren and Sourander has been considered the standard reference for brain iron quantification [7], 
which presents a wide belief that iron in the brain levels off after a certain age (30-40 years old) for 
many structures. For instance, many studies have shown that iron level is low in newborn brain and 
quickly increases during rapid brain growth which concurs with the peak of myelinogenesis [73] 
until the age of 20 to 30, and then it reaches stable levels [7, 94]. However, this was not seen in all 
brain structures. Hallgren’s and Sourander’s work showed that iron in the globus pallidus increased 
until the age of 30 years old. Their results also suggest that the iron increase in the putamen and the 
caudate nucleus is slow and reaches a maximum value around the age of 60 years old. On the other 
hand, the iron level in the thalamus reaches its peak at the age of 30 years old, and then appears to 
decline after that age. Recent studies used phase information to evaluate iron content in the brain 
[66, 88, 95]. For instance, Xu et al. [66] showed that iron uptake remained age dependent in the 
putamen, red nucleus and frontal white matter but not  in the globus pallidus, substantia nigra and 
caudate nucleus where, after a rapid increase in the first two decades, iron reaches a plateau.  
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Putamen: Our results showed that iron content in the putamen remained age dependent throughout 
5 decades and are in agreement with results of Xu et al [66]. This agrees with Hallgren’s and 
Sourander’s work which showed that iron in the putamen was age dependent and did not reach its 
maximum until the 6th decade, in agreement with a study by Aquino et al. [92] showing a slow rate 
of increase and a variability after the age of 50. We found that both the volume of affected tissue 
with high iron content and the average iron content per pixel increased with age, and in some cases 
the rate of iron deposition are dramatically changed after the age of 40 years old in the following 
structures: PUT, CN, GP and PT. This increase in iron may not be as rapid as that occurs in the first 
two decades of life, but nevertheless is present in most people (Figure 4.13a, b and c).  
Red nucleus: Our results showed that iron content in the red nucleus remained age dependent 
throughout the 5 decades we studied and are in agreement with Xu et al.’s results [66]. However, 
Hallgren and Sourander’s work  showed a rapid increase in the first 2 decades (first 2 decades data 
were not available in our study), whereas no conclusions were drawn regarding iron in the red 
nucleus after the age of 20 due to technical difficulties. 
Globus pallidus: In several studies [7, 78], iron in the globus pallidus was shown to increase 
rapidly and level off after the age of 30 years old, whereas our results as well as Xu et al.’s [66] 
show a linear decrease as a function of age. From Table 4.2 one can see that the iron concentration 
in RII grows very fast with age, but the iron concentration in the whole structure grows more 
slowly. As a result, we believe that the two region analysis is necessary for detecting more subtle 
brain iron changes.  
Substantia nigra: None of these studies (including our study) showed significant changes in SN 
iron content as a function of age (Figure 4.16). However, the Hallgren and Sourander work showed 
a rapid increase in the first 2 decades and inconclusive results for older ages, and Aquino et al. [92] 
showed a rapid increase until the age of 15, and then the iron content reaches a plateau (note that 
our study did not cover the age range from 0 to 19 years old). No correlation with our study can be 
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drawn since the first two decades data were not available. 
Caudate nucleus: According to Hallgren and Sourander, the iron in the caudate nucleus was seen to 
behave in a similar fashion to the putamen, showing a slow increase reaching a maximum value at 
age 60 years old. Xu et al [66]. showed that iron in the caudate nucleus increased slightly with age. 
Both results contrast with our results as we see increases in iron content with age using the two 
region-of-interest analysis. On the other hand, Aquino et al. [92] showed an almost flat iron content 
with age. For the CN, we have found that iron increased slowly in the early ages, but this rate rises 
dramatically after the age of 40 (Figure 4.5a, b).  
Thalamus: According to Hallgren and Sourander, iron in the thalamus increased in the early stages, 
reached a maximum at the age of 30, and then it started declining. Xu et al. showed that iron in the 
thalamus is almost constant with respect to age. However, our results showed that iron in this 
structure increases linearly with age (Figure 4.9e, f). 
Pulvinar thalamus: The pulvinar thalamus has not yet been analyzed for its iron content in the 
literature. Here, we show that the iron concentration in the PT increased linearly with age similar to 
the rest of the basal ganglia and main body of the thalamus (Figure 4.15). The PT is of particular 
interest in the study of multiple sclerosis where it appears as if major increases in iron content can 
occur for subjects under the age of 40 years old. 
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Figure 4.14: Expressing average iron content (iron density) in the PUT for RII and the whole 
region with different units: µg Fe/g tissue, Siemens phase units (SPU), radians and ppm.  The solid 
triangles and squires are for the left and right side PUT for normal subjects. The dashed line and 
solid line are the fits of the left and right PUT for normal subjects. 
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Figure 4.15: Expressing average iron content (iron density) in the PT for RII and the whole region 
with different units: µg Fe/g tissue, Siemens phase units (SPU), radians and ppm.  The solid 
triangles and squires are for the left and right side PUT for normal subjects. The dashed line and 
solid line are the fits of the left and right PUT for normal subjects. 
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Figure 4.16: Expressing average iron content (iron density) in the SN for RII and the whole region 
with different units: µg Fe/g tissue, Siemens phase units (SPU), radians and ppm.  The solid 
triangles and squires are for the left and right side PUT for normal subjects. The dashed line and 
solid line are the fits of the left and right PUT for normal subjects. 
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Table 4.4: Comparison between the two hemispheres of phase related iron measures 
 Iron-Phase-RII Average iron-Phase-RII Iron-Phase-Total Average iron-Phase-Total Area-Phase-RII 
 
Mean 
(rad×mm3) 
SD 
Number of 
L>R, L=R, 
L<R 
P 
value 
Mean 
(10-3 
rad) 
SD 
Number of 
L>R, L=R, 
L<R 
P 
value 
Mean 
(rad×mm3) 
SD 
Number of 
L>R, 
L=R, L<R 
P 
value 
Mean 
(10-3 
rad) 
SD 
Number of 
L>R, 
L=R, L<R 
P 
value 
Mean 
(10-3%) 
SD 
Number 
of L>R, 
L=R, L<R 
P 
value 
PUT -3.18 19.14 40/14/46 0.09 2.11 44.43 49/16/35 0.64 -2.59 27.25 44/0/56 0.33 0.76 20.12 50/0/50 0.70 -0.77% 4.98% 41/14/45 0.12 
CN 3.54 13.71 61/0/39 0.01 0.66 26.39 51/0/49 0.8 7.28 14.84 70/0/30 <0.01 7.19 19.26 59/5/36 <0.01 1.28% 6.56% 60/0/40 0.05 
GP 0.87 26.76 54/0/46 0.75 -5.68 52.52 47/6/47 0.29 4.81 26.24 58/0/42 0.07 4.83 26.78 57/3/40 0.07 0.68% 5.99% 55/0/45 0.26 
RN 1.13 3.19 60/18/22 <0.01 6.58 19.34 51/22/27 <0.01 0.73 5.18 55/0/45 0.16 5.56 25.95 59/1/40 0.03 1.67% 4.86% 56/20/24 <0.01 
PT -1.36 4.34 34/0/66 <0.01 -1.20 10.57 42/3/55 0.27 -1.06 5.90 40/0/60 0.08 -6.58 15.56 31/3/66 <0.01 -2.68% 6.60% 35/0/65 <0.01 
SN -0.89 5.76 35/10/55 0.12 -2.54 28.24 37/13/50 0.32 -3.24 10.13 40/0/60 <0.01 -6.21 33.18 45/1/54 0.07 -0.49% 3.82% 36/10/54 0.19 
THA 0.65 12.20 53/0/47 0.61 0.13 6.76 40/8/52 0.86 -0.72 14.40 48/0/52 0.63 -0.44 7.06 39/8/53 0.55 -0.17% 4.04% 46/0/54 0.68 
PUT: Putamen.    CN: Caudate Nucleus.   GP: Globus Pallidus.   RN: Red Nucleus.   PT: Pulvinar Thalamus.   SN: Substantia Nigra.   THA: 
Thalamus                                         
Mean: mean of the two hemispheres difference from left minus right hand side.                                                                                                                                 
SD: standard deviation.                                                                                                                                                                                                                          
L>R: the amount of patients that show larger value in the left hemisphere. L=R: the amount of patients that show equal values in both 
hemispheres. L<R: the amount of patients that show larger value in the right hemisphere.     
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Table 4.5: Comparison between the two hemispheres of magnitude related iron measures 
 Iron-Magnitude-RII Average iron-Magnitude-RII Iron-Magnitude-Total Average iron-Magnitude-Total 
 
Mean 
(sec-1×mm3) 
SD 
Number of L>R, 
L=R, L<R 
P value 
Mean 
 (10-3ms-1) 
SD 
Number of L>R, 
L=R, L<R 
P value 
Mean  
(sec-1×mm3) 
SD 
Number of L>R, 
L=R, L<R 
P value 
Mean  
(10-3ms-1) 
SD 
Number of L>R, 
L=R, L<R 
P value 
PUT 0.42 1.02 70/0/30 <0.01 0.07 0.68 50/14/36 0.3 0.51 1.23 70/0/30 <0.01 0.65 0.83 76/7/17 <0.01 
CN 0.46 0.82 80/2/18 <0.01 0.17 0.48 55/20/25 <0.01 0.66 0.80 85/100 <0.01 0.81 0.93 83/100 <0.01 
GP 0.29 1.13 60/5/35 0.01 0.04 1.60 51/16/33 0.81 0.57 1.41 70/0/30 <0.01 0.55 1.20 66/5/29 <0.01 
RN 0.02 0.25 58/3/39 0.43 0.11 0.62 49/21/30 0.08 0.00 0.21 54/0/46 0.97 0.17 1.01 59/7/34 0.09 
PT 0.04 0.30 47/4/49 0.23 -0.03 0.53 41/17/42 0.6 0.05 0.36 55/0/45 0.17 -0.03 0.79 44/9/47 0.76 
SN 0.08 0.31 55/0/45 <0.01 0.18 0.83 48/19/33 0.03 0.20 0.54 68/0/32 <0.01 0.67 1.53 62/10/28 <0.01 
THA 0.20 1.47 50/0/50 0.08 0.06 0.45 43/28/29 0.12 0.20 1.30 52/0/48 0.13 0.07 0.57 43/13/44 0.3 
PUT: Putamen.    CN: Caudate Nucleus.   GP: Globus Pallidus.   RN: Red Nucleus.   PT: Pulvinar Thalamus.   SN: Substantia Nigra.   THA: 
Thalamus                                         
Mean: mean of the two hemispheres difference from left minus right hand side.                                                                                                                                  
SD: standard deviation.                                                                                                                                                                                                                          
L>R: the amount of patients that show larger value in the left hemisphere. L=R: the amount of patients that show equal values in both 
hemispheres. L<R: the amount of patients that show larger value in the right hemisphere.      
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This study has a number of limitations. First, besides iron, there are also some other elements 
that can contribute to phase changes such as calcium, magnesium, copper, and zinc. However, 
they would tend to reduce the effects of iron. Also, we cannot separate these effects from those 
of iron especially if these other elements are randomly mixed with the iron. Second, since there 
was only a single gradient echo acquired, it was not possible to calculate an R2* map or to create 
directly a ∆R2∗	map. Therefore, we had to assume that we could use the original signal from a 
younger population as a means to normalize the data and create an effective ∆R2∗ map. These 
variations might account for some of the spread of ∆R2∗	as a function of age. Although this 
appears to have worked reasonably well, there can be problems associated with confounding 
factors such rf coil loading, T1 values, and water content from person to person. Third, the 
limitation on drawing further conclusions regarding the effects of iron changes with age comes 
from the fact that the age range was only from 20 to 69 years. Including younger and older 
subjects would have been of interest as well. 
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Chapter Five    Assessing the changes of susceptibility in the human brain 
nuclei over lifespan and investigating the correlation between susceptibility 
and in vivo iron content 
Introduction 
Iron is the most abundant transition metal in the brain, and plays a key role in a number of brain 
cellular processes including oxygen transport, electron transfer, neurotransmitter synthesis, 
myelin production and mitochondrial function [2, 38]. However, the useful redox cycling 
between ferrous (Fe2+) and ferric (Fe3+) iron can also make iron toxic when it is not safely bound 
in ferritin, because free or poorly liganded Fe(II) can react with H2O2 to generate highly reactive 
hydroxyl ions [96]. Both conditions of iron overload and iron deficiency (Hare et al., 2013) are 
associated with human brain diseases. Elevated iron is often a feature of  neurodegenerative 
diseases such as multiple sclerosis (MS) [97], Alzheimer’s disease [98], Parkinson's disease [99], 
Huntington’s disease [100], and ferritinopathies [101]. Histological in vitro analysis has 
demonstrated iron accumulation rates in different gray matter (GM) structures are different 
throughout an individual’s lifetime [7]. To further elucidate the involvement of iron in 
neurodegenerative disorders, a robust in vivo quantitative non-invasive assessment of normal 
brain iron deposition over time is essential. In this paper, we will attempt to provide such a 
baseline that can be used to differentiate normal from abnormal iron levels in patients with 
potential increases in iron content. 
A variety of magnetic resonance imaging (MRI) methods have been used to quantify brain iron 
including FDRI (field-dependent relaxation rate increase), R2, R2*, phase and quantitative 
susceptibility mapping (QSM) [6, 55, 67, 82]. FDRI is a specific indicator for iron content, but it 
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yields nosier data, longer scan times and lower spatial resolution. Although R2 has a linear 
correlation with iron concentration [55], parameters generated from gradient echo sequences 
(GRE) are more sensitive to the local susceptibility induced magnetic field inhomogeneity 
caused by the presence of iron [102]. Magnetic susceptibility differences in brain tissues can 
come from a variety of sources such as paramagnetic ferritin iron, blood, diamagnetic myelin 
content, chemical exchange and fiber orientation [103]. Since the amount of myelin content is 
negligible, it is currently assumed that the magnetic susceptibility of gray matter is dominated by 
ferritin iron [7]. R2* has been shown to be a sensitive MRI parameter to estimate iron content in 
deep gray matter [55]. However, besides iron, R2* is also affected by water content. For example, 
in edema, signal from iron will be canceled out due to water's low R2* property. Also R2* 
increases proportionally to the concentration of myelin. In contrast, iron and myelin content 
manifest in opposite phase (field) behavior because the former is paramagnetic while the latter is 
diamagnetic. This makes gray-white matter (GM-WM) contrast in phase and QSM superior than 
that in R2*.  
Phase has been used to represent iron content in the past [6, 90]. However, phase mapping 
suffers from non-locality of the magnetic field distribution, so it does not provide accurate local 
anatomical information [104]. This makes the estimation of iron content in 3D structures 
impossible using phase images. In the last few years, QSM has been introduced to overcome the 
non-local effects of phase and to provide the susceptibility maps [35, 105-107]. QSM is a post-
processing method which reconstructs source images directly from the phase images [33, 34]. 
Both post mortem [67, 108] and in vivo [82, 106, 107, 109] experiments have demonstrated 
strong correlations between magnetic susceptibility assessed by QSM and known iron 
concentrations of different structures in the brain [82]. However, the reported correlations were 
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not consistent between the in vivo and in vitro results, and these in vivo studies had limited 
sample size and age range.  
To provide a measure of iron over a broad age range, we studied a group of 180 normal subjects 
in vivo ranging in age from 20 years old to 69 years old by measuring the 3D structural magnetic 
susceptibility of seven sub-cortical gray matter nuclei. Our goal is to produce a quantitative 
magnetic susceptibility baseline as a function of age for each structure. These values will be used  
to compare with the regional iron concentrations taken from the histochemical post mortem 
study published by Hallgren and Sourander [7] to establish an in vivo quantitative conversion 
factor between magnetic susceptibility and iron concentration.  
Materials and Methods 
Subjects 
A total of 188 healthy subjects were enrolled and scanned at Dalian First Affiliated Hospital, 
China. They were recruited from university staff, students and their relatives. Exclusion criteria 
were history of neurological or psychiatric conditions, head trauma with loss of consciousness 
for more than 5 min, drug and alcohol abuse, and brain surgery. These participants did not show 
any focal parenchymal loss, infarction, resection, or large hyperintensities in their brain on T2-
weighted images. Seven subjects were excluded because of motion during scans. Two subjects 
didn’t have their age recorded. Another four subjects weren’t included because certain interested 
gray matter nuclei were lost after QSM processing. By excluding those cases, we included 175 
normal subjects in this study (age, 45.1±14.2 years; range, 20-69 years; 86 females, 89 males). A 
consent form approved by the hospital’s research ethics committee was provided for all 
volunteers to read, understand, and sign. 
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MR imaging 
MR imaging of the brain was performed using a 1.5-Tesla (T) MR scanner (HD, General Electric 
Co., Milwaukee, WI, USA) equipped with an eight-channel phased array head coil by using 
identical protocols. The imaging plane was oriented parallel to the anterior-posterior 
commissural (AC-PC) line. A three-dimensional gradient-echo sequence was applied to acquire 
images for QSM reconstruction. The imaging parameters included: TR/TE = 53 ms/40 ms, flip 
angle = 20°, slice thickness = 3 mm, bandwidth = 31.25 Hz/pixel, field-of-view (FOV) = 24 cm 
and matrix size (Nx x Ny) = 384 x 320, yielding an in-plane resolution of 0.60 mm by 0.75 mm. 
The total scan time was 6 minutes 28 seconds. 
Image processing and Analysis 
QSM images were reconstructed by using our in-house Matlab based toolbox SMART 2.0 (MRI 
Institute for Biomedical Research, Detroit, MI, USA). Four steps were applied to generate the 
resulting QSM images: : brain extraction (BET [110]), phase unwrapping (3D-SRNCP [111]), 
background field removal (SHARP [106]) and an iterative QSM approach [34, 35]. The 
magnitude images were used to extract the brain tissue. The original susceptibility maps were 
derived by the following equation (for a right handed system) [35]:  
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where φ(r) is the phase distribution, TE is the echo time, B0 is the main magnetic field strength, γ 
is the gyromagnetic ratio for hydrogen protons, kx, ky and kz are coordinates in k-space. The ill-
posed nature from the denominator term, which is the Green’s function, was overcome by an 
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iterative approach to obtain artifact free susceptibility maps [34]. An example resulting QSM 
image and images from intermediate processing steps are shown in Figure 5.1.  
 
Figure 5.1: Left: Original phase image. Middle: Phase image after performing brain extraction, 
phase unwrapping and background removal. Right: Magnetic susceptibility map (iterative QSM 
map). The three images are the same slice from the same case. In the susceptibility map, bright 
signal intensities in the grey matter nuclei represent high magnetic susceptibility which relates to 
high iron content.  
 
Magnetic susceptibility values are relative, therefore the susceptibility measurements need to be 
referenced to a particular region. The cerebrospinal fluid (CSF) is usually chosen as the reference 
region [62, 112]. However, due to the fact that the CSF shows a large range of susceptibility 
values [113], we quoted the values measured directly from the susceptibility maps in this study 
to avoid the errors caused by reference selection. If white matter dominates the signal then these 
will be susceptibility changes relative to white matter.  
The susceptibility values in the regions of interest (ROIs) were assessed by segmenting these 
structures manually based on their anatomical features in the susceptibility maps. To evaluate the 
magnetic susceptibility of each nucleus in 3D, multiple slices were outlined to cover each entire 
structure (Figure 5.2). The 3D ROIs were traced and analyzed using an in-house developed 
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software SPIN (Signal Processing in NMR, MRI Institute for Biomedical Research, Detroit, MI, 
USA). The gray matter nuclei assessed in this study included: Caudate Nucleus (CN), Globus 
Pallidus (GP), Putamen (PUT), Thalamus (THA), Pulvinar Thalamus (PT), Red Nucleus (RN) 
and Substantia Nigra (SN). Large blood vessels and the dark rims around the structures were 
excluded when drawing the ROIs. Bilateral structures were traced on the same slices. The criteria 
for defining these structures are as follows: 
CN: The head of the CN will be included. The most superior slide is the one first shows the head 
of CN. We omit the thin body part of CN because that part is vascularized, so it's hard to 
distinguish whether the signal is from veins or iron. Also which 3mm thickness, the 
susceptibility value of the thin body of CN is not trustable. The ROIs of the left and right CN 
were drawn on 6-7 continuous slices until the structure vanished into the sinus.  
PUT: Five to six continuous slices were outlined. PUT starts one slice lower than the CN.  
GP: GP starts from 1-2 slices lower than the PUT and usually presents on 4 to 5 continuous 
slices. It ends on the same level or one slice lower than the PUT. The slices with striations were 
avoided.  
RN: The circular shaped RN appears on 2 continuous slices, which is easy to identify.  
SN: The contours of the SN were delineated on 3 continuous slices, which included the same 
slices where the RN was drawn and the slice below RN.  
THA: The THA was traced from inferior to superior. It starts from the 2nd slice above the SN 
and continues for 4 slices.  
PT: The ROI for the pulvinar thalamus was drawn on the same slices as the THA.  
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Figure 5.2. Multi-slice 3D ROIs drawn on the QSM maps. Structures include: CN: caudate 
nucleus (blue), GP: globus pallidus (green blue), PUT: putamen (orange), SN: substantia nigra 
(yellow orange), RN: red nucleus (violet), PT: pulvinar thalamus (red), THA: thalamus (green). 
Numbers on the images are the slice number of the data set. Each data set contain 40 slices.  
 
To correlate the magnetic susceptibility with the iron concentration reported by Hallgren & 
Sourander, the scatter plots of non-heam iron versus age in GP, PUT and THA were duplicated 
electronically from a scanned version of Hallgren & Sourander’s paper by using 
WebPlotDigitizer v2.6 (developed by Ankit Rohatgi). The reason to duplicate their data was to 
match the subject age range when doing the comparisons.  
Statistical analysis 
The statistical analysis was performed using Microsoft Excel 2013 and Matlab R2012a 
(Mathworks, Natick, MA). A p value of less than 0.05 was considered to be significant. The 
susceptibility differences between left and right hemispheres in different structures of interest 
were tested by paired t tests. Pearson correlation analysis was applied to investigate the relation 
between susceptibility and age in each structure. A Pearson correlation coefficient larger than 0.5 
was considered to be a strong relationship. Linear regression models were used to fit the data. In 
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some structures, the susceptibility variance is not always homogeneous across age. The normal 
subjects were separate into 5 groups on the basis of their age (each decade as a group). The 
susceptibility means and standard deviations (SDs) were calculated.  
To study the relationship between magnetic susceptibility and iron concentration, two methods 
were used in our study. First, the iron concentrations published by Hallgren & Sourander in 
scatter plots (GP, PUT and THA) were grouped into 5 bins (each decade as a group for subjects 
from 21 to 70 years old) as we did for the susceptibility data. With those averages from matched 
age groups, linear regression models were used to test the correlation between the iron 
concentrations assessed with postmortem samples and the magnetic susceptibility. Another 
method was by estimating the iron concentration in the PUT for each subject on the basis of age 
by using the equation published in Hallgren & Sourander’s paper because the PUT shows the 
best age dependency, and then linear regression was used to find the correlation between 
susceptibility and the calculated iron concentration.  
Results 
Difference between two hemispheres and comparison between different gray matter nuclei 
According to the paired t-tests, significant differences between the left and right hemispheres 
were found in SN and THA for all the 5 decades. For other gray matter nuclei studied in this 
paper, several age bins showed statistically differences (p<0.05). Table 5.1 shows the detailed 
statistics of the hemisphere comparisons.  The average magnetic susceptibility values of different 
decades in the gray matter nuclei are as shown in Figure 5.3. The mean values and the SDs 
plotted in Figure 5.3 were calculated by including all the left and right hand side measurements. 
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Overall, the GP had the highest susceptibility, followed in decreasing iron content by the SN, RN, 
PUT, CN, PT and THA.  
 
Figure 5.3: The average susceptibility for each of the 5 age intervals in different iron rich grey 
matter nuclei. The error bars represent plus/minus 2xSD. Values were calculated by including 
both of the left and right hemispheres. CN: caudate nucleus. GP: globus pallidus. PUT: putamen. 
SN: substantia nigra. RN: red nucleus. PT: pulvinar thalamus. THA: thalamus.  
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Table 5.1. Statistics table of the susceptibility comparisons between the left and right hemispheres in difference intervals. 
Decade CN GP PUT SN RN PT THA 
21-30 yr 
Left (ppb) 29.69±5.97 129.34±21.47 30.91±8.87 90.08±24.74 46.34±20.01 29.51±8.16 3.19±4.87 
Right (ppb) 31.09±7.06 124.42±18.57 31.90±9.38 79.91±20.84 43.90±19.42 25.25±9.02 -3.14±4.79 
p 0.1532 0.0085 0.3358 0.0000 0.0445 0.0009 0.0000 
31-40 yr 
Left (ppb) 35.37±10.37 129.03±23.60 42.76±12.65 107.85±27.45 70.40±25.60 38.83±13.84 2.38±5.72 
Right (ppb) 35.17±10.00 127.21±21.05 44.21±11.99 94.81±24.67 68.63±24.36 35.70±13.38 -3.09±5.58 
p 0.901563 0.3228 0.1402 0.0000 0.3844 0.0040 0.0000 
41-50 yr 
Left (ppb) 35.73±9.72 147.66±29.20 54.89±12.67 113.5±32.16 99.99±22.40 43.37±18.14 2.9±6.61 
Right (ppb) 39.59±7.83 147.71±30.61 56.44±13.70 104.45±31.47 99.70±28.23 43.82±19.32 -2.41±7.23 
p 0.0090 0.9816 0.3084 0.0013 0.9126 0.8014 0.0002 
51-60 yr 
Left (ppb) 41.77±10.49 143.62±29.83 63.82±17.40 114.01±32.81 94.67±26.02 39.39±12.42 -2.35±5.92 
Right (ppb) 48.12±11.86 146.23±28.75 69.75±19.19 101.93±33.09 85.36±25.42 34.19±11.58 -8.48±5.44 
p 0.0002 0.2753 0.0000 0.0000 0.0000 0.0001 0.0000 
61-70 yr 
Left (ppb) 49.27±13.32 133.56±23.92 75.43±24.28 114.32±21.99 96.28±34.03 37.43±15.13 -1.97±6.66 
Right (ppb) 49.13±14.83 133.07±21.20 70.72±22.22 101.84±22.69 91.50±27.88 34.39±19.44 -8.07±7.89 
p 0.943329 0.854003 0.0039 0.0000 0.1113 0.1186 0.0006 
Susceptibility values were quoted as Mean ± Standard deviation for each decade. Left: left hemisphere. Right: right hemisphere. p: p 
value of the paired t tests. CN: caudate nucleus. GP: globus pallidus. PUT: putamen. SN: substantia nigra. RN: red nucleus. PT: 
pulvinar thalamus. THA: thalamus.  
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Linear relationship between susceptibility and age in iron rich deep gray matter nuclei  
Figure 5.4 shows the susceptibility changes as a function of age in the gray matter nuclei 
analyzed in this study. Except for the SN and THA, all other nuclei including the CN, GP, PUT, 
RN and PT are plotted by combining the values from both hemispheres. The measurements of 
the right SN and right THA are presented in Figure 5.4 because all 5 decades show statistical 
difference between the two hemispheres in those two structures. The slopes and intercepts of the 
fitted linear equations are summarized in Table 5.2. The Pearson correlation coefficients for each 
relation are also listed in Table 5.2.  
Table 5.2: The parameters of the linear fitting equations for Susceptibility vs. Age 
  ૏ ൌ ۯ ൈ ܉܏܍ ൅ ۰ 
  A (ppb/year) B (ppb) Pearson's Correlation Coefficient 
CN Left 0.44±0.05 18.20±2.54 0.53±0.06 
Right 0.50±0.06 18.24±2.65 0.56±0.06 
Both 0.47±0.04 18.23±1.84 0.54±0.05 
GP Left 0.24±0.14 126.10±6.76 0.13±0.08 
Right 0.38±0.14 118.99±6.55 0.20±0.07 
Both 0.26±0.08 122.45±3.92 0.17±0.05 
PUT Left 1.01±0.08 7.18±3.74 0.70±0.05 
Right 1.14±0.08 3.94±3.95 0.72±0.05 
Both 1.08±0.06 5.56±2.73 0.71±0.04 
SN Left 0.52±0.16 84.71±7.34 0.25±0.08 
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Right 0.47±0.15 75.31±7.07 0.24±0.08 
Both 0.50±0.11 80.01±5.18 0.24±0.05 
RN Left 1.25±0.15 25.11±6.91 0.55±0.06 
Right 1.12±0.15 26.90±6.88 0.51±0.07 
Both 1.19±0.10 26.00±4.88 0.53±0.05 
PT Left 0.19±0.08 29.56±3.58 0.18±0.07 
Right 0.18±0.08 26.67±3.92 0.16±008 
Both 0.18±0.06 28.11±2.66 0.17±0.05 
THA Left -0.15±0.03 7.42±1.53 -0.33±0.07 
Right -0.16±0.03 2.31±1.57 -0.35±0.07 
Both -0.16±0.03 4.90±1.21 -0.31±0.05 
RN (20-50 yr) Both 2.42±0.17 -13.84±6.31 0.70±0.05 
SN (20-50 yr) Right 0.98±0.28 58.80±10.27 0.33±0.10 
PT (20-50 yr) Both 0.72±0.11 10.61±3.88 0.43±0.06 
Left: left hemisphere. Right: right hemisphere. Both: left and right hemisphere together. For RN, 
SN and PT, data are also fitted for subjects between 20 and 50 years old. 
 
In the PUT, CN and RN, the magnetic susceptibility appears to be linearly correlated with age 
(R>0.5, p<0.05). The susceptibility distributions across ages are quite scattered in the GP, SN, 
PT and THA with limited age dependency (R<0.3). According to the slopes, the susceptibility of 
the RN shows the most rapid increase as a function of age with a changing rate of 1.19±0.10 
ppb/year, and then followed by the PUT (1.08±0.06 ppb/year), SN (0.50±0.11 ppb/year), CN 
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(0.47±0.04 ppb/year), GP (0.26±0.08 ppb/year) and PT (0.18±0.06 ppb/year). The THA shows 
decreased susceptibility with age and with 0.16±0.03 ppb/year. Overall, it appears as if the 
susceptibility values increase with an almost constant rate till around 50 years old and then level 
off. By only fitting the data between 20 to 50 years, we found steeper slopes and better 
correlations as shown in Table 5.2. Fittings of the data between 20 to 50 years for the RN and SN 
are shown in Figure 5.4.  
Correlation between susceptibility and iron concentration 
For the data extracted from the scatter plots in Hallgren & Sourander’s paper, after excluding the 
subjects younger than 20 years old and older than 70 years old, 47 subjects remained with an age 
of 43.6 ± 14.2 years old. There is no age difference between our normal controls and those 47 
subjects. Figure 5.5 shows the correlation between susceptibility measured by MRI in vivo and 
iron concentration. The correlation slope is determined by linear regression. Two approaches 
served to predict iron concentration as explained in the Methods section. By using the group 
average approach (Figure 5.5 Left), we found χ ൌ 0.89ሺേ0.03ሻ ∗ Fe െ 48.51ሺേ4.09ሻ. By using 
the equation based approach (Figure 5.5 Right), we found χ ൌ 0.93ሺേ0.05ሻ ∗ Fe െ
59.49ሺേ6.43ሻ. The correlation slopes investigated by the two methods are very close. The 
method we applied for reconstructing susceptibility maps need to be corrected by a factor of 1.16 
[67]. After correcting for this underestimate, the correlation slopes become 1.03±0.03 ppb per µg 
iron/g wet tissue and 1.08±0.06 ppb per µg iron/g wet tissue for the two approaches, respectively.  
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Figure 5.4: Magnetic susceptibility changes with age in different grey matter nuclei. The susceptibility values reported in this study 
are highly consistent with Li et al.’s study [77]. Strong positive linear correlations are found in PUT, CN and RN. Mild positive linear 
correlations are shown in GP, SN and PT and good negative linear correlation in THA. In RN, SN and PT, the linear correlations are 
better if only looking at the data between 20 to 50 years old. PUT: putamen. CN: caudate nucleus. RN: red nucleus. GP: globus 
pallidus. SN: substantia nigra. PT: pulvinar thalamus. THA: thalamus. Black circles: current study data. Blue dots: values published 
by Li et al. from Duck University. Black line: linear regression fitting for the current study data. Red squares: average susceptibility of 
each decade for current study. Vertical error bars: two standard deviations.  
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Figure 5.5: Relationship between magnetic susceptibility and iron concentration determined 
with linear regressions. Upper: It is estimated by correlating the bin averages of susceptibility 
with matched bin averages of iron concentrations extracted from Hallgren & Sourander’s scatter 
plots. The structures included in this plot are GP, PUT and THA because Hallgren & Sourander 
only provided the scatter plots of those three structures which we also analyzed in our study. 
Lower: It is estimated by correlating susceptibility with iron concentration calculated from iron-
age equation [7] in PUT, which shows the best age dependency. The correlations found with the 
two methods are similar.  
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Discussion 
Linear correlations between magnetic susceptibility and age were revealed in almost all the gray 
matter nuclei studied in this manuscript (Figure 5.4). Some were strong such as in PUT, CN, RN 
and THA, and some were weak such as in GP, SN, and PT. The strength of the correlation also 
depended on what age range was used. Brain gray matter nuclei iron quantification with age has 
been investigated with a number of methods such as R2* [61, 92, 114], phase [6, 66], and 
histopathology [7]. Since our data included normal subjects from 20 to 70 years old, we 
examined the susceptibility by comparing the same age range with other studies. R2* studies by 
Aquino et al. (for PUT, CN, GP and SN) [92] and Li et al. (for PUT, CN, GP, SN and RN) [77] 
reported exponential growth in R2* with age, which is consistent with the cadaveric study by 
Hallgren & Sourander. However, after eliminating the young subjects (younger than 20 years old) 
in those three studies, all correlations turn linear. The linear correlation between phase and age is 
also found in some previous publications [6, 66]. The best linear age dependency is shown in the 
PUT [6, 7, 61, 66, 77, 92, 114] and sometimes in the CN [6, 61, 77, 114] with R2*/phase/iron 
growing well into the 80s. This is consistent with our susceptibility trends. Linear regression 
curves in the GP [6, 7, 77, 92] and SN [6, 77, 92] are flat for R2*/phase/iron for subjects with 
ages of 20 years and up; this is consistent with our findings. A detailed comparison between 
studies is shown in Table 5.3.  
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Table 5.3: Reported linear correlation between iron related parameters and age. 
Structures Authors/Method Linear correlation 
(20 yr and up) 
Field 
(Tesla) 
Subject age 
range 
Sample 
size 
PUT Susceptibility/This study Strong 1.5 20-69 175 
R2*/Aquino et al. (2009) Strong 1.5 1-80 80 
R2*/Cherubini et al. (2009) Strong 3 20-70 100 
R2*/Peran et al. (2009) Strong 3 20-41 30 
∆R2*/Haacke et al. (2010) Strong 1.5 20-69 100 
R2*/Li et al. (2013) Strong 3 7-83 174 
Phase/Xu et al. (2008) Strong 1.5 22-78 78 
Phase/Haacke et al. (2010) Strong 1.5 20-69 100 
Susceptibility/Li et al(2013) Strong 3 1-83 181 
Cadaveric/Hallgren& 
Sourander (1958) 
Strong   81 
CN Susceptibility/This study Strong 1.5 20-69 175 
R2*/Aquino et al. (2009) Weak 1.5 1-80 80 
R2*/Cherubini et al. (2009) Good 3 20-70 100 
R2*/Peran et al. (2009) Strong 3 20-41 30 
∆R2*/Haacke et al. (2010) Strong 1.5 20-69 100 
R2*/Li et al. (2013) Strong 3 7-83 174 
Phase/Xu et al. (2008) Weak 1.5 22-78 78 
Phase/Haacke et al. (2010) Good 1.5 20-69 100 
Susceptibility/Li et al(2013) Weak 3 1-83 181 
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RN Susceptibility/This study Strong 1.5 20-69 175 
∆R2*/Haacke et al. (2010) Strong 1.5 20-69 100 
R2*/Li et al. (2013) Weak 3 7-83 174 
Phase/Xu et al. (2008) Weak 1.5 22-78 78 
Phase/Haacke et al. (2010) Strong 1.5 20-69 100 
Susceptibility/Li et al(2013) No 3 1-83 181 
GP Susceptibility/This study No 1.5 20-69 175 
R2*/Aquino et al. (2009) Weak 1.5 1-80 80 
R2*/Peran et al. (2009) No 3 20-41 30 
∆R2*/Haacke et al. (2010) Good 1.5 20-69 100 
R2*/Li et al. (2013) Weak 3 7-83 174 
Phase/Xu et al. (2008) Weak 1.5 22-78 78 
Phase/Haacke et al. (2010) No 1.5 20-69 100 
Susceptibility/Li et al(2013) Weak 3 1-83 181 
Cadaveric/Hallgren& 
Sourander (1958) 
No   81 
SN Susceptibility/This study Weak 1.5 20-69 175 
R2*/Aquino et al. (2009) No 1.5 1-80 80 
∆R2*/Haacke et al. (2010) Good 1.5 20-69 100 
R2*/Li et al. (2013) No 3 7-83 174 
Phase/Xu et al. (2008) No 1.5 22-78 78 
Phase/Haacke et al. (2010) Good 1.5 20-69 100 
Susceptibility/Li et al(2013) No 3 1-83 181 
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PT Susceptibility/This study No 1.5 20-69 175 
∆R2*/Haacke et al. (2010) Strong 1.5 20-69 100 
Phase/Haacke et al. (2010) Good 1.5 20-69 100 
THA Susceptibility/This study Week 1.5 20-69 175 
R2*/Cherubini et al. (2009) No 3 20-70 100 
R2*/Peran et al. (2009) No 3 20-41 30 
∆R2*/Haacke et al. (2010) Strong 1.5 20-69 100 
Phase/Xu et al. (2008) No 1.5 22-78 78 
Phase/Haacke et al. (2010) Week 1.5 20-69 100 
Cadaveric/Hallgren& 
Sourander (1958) 
Good Negative   81 
Strong: R>0.5; Good: 0.3<R<0.5; Weak: 0.2<R<0.3; No: R<0.2.  
R is the correlation coefficient.  
 
To examine the stability and consistency characteristics of susceptibility mapping, we plotted the 
susceptibility measurements from Li et al.’s study [77] on top of ours for subjects 20 years and 
older (Figure 5.4). The plots clearly show consistency between the two studies. Although our 
imaging parameters are different, it is encouraging to note that both approaches yield similar 
results. This suggests that comparisons across different QSM algorithms, different types of 
magnets and different centers is viable. 
A negative relationship between the susceptibility with age was found in the thalamus in this 
study. This is consistent with what Hallgren & Sourander reported in their postmortem work. 
They claimed a rise in the iron content up to about 35 years old and then a decrease (although 
they had a limited number of cases between 20 to 30 years). This trend is consistent with Bilgic 
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et al.’s finding that the average susceptibility value in the thalamus was lower in the elderly 
relative to the young [82]. Another comment we would like to make here is that the measured 
susceptibility values are relative to that tissue which dominates the signal and established the 
main frequency in the MR experiment and in this case that is the white matter. If the iron content 
in the white matter goes up with age, then the downward trend we found here for the thalamus 
would tend to flatten out in reality. This requires further study.  
The correlation between magnetic susceptibility and iron concentration found in this manuscript 
is 0.89±0.03 ppb/µg Fe/g wet tissue by the age bin method and 0.93±0.05 ppb/µg Fe/g wet tissue 
by the iron-age function method [7] in PUT. The two slopes are close to each other. After 
applying the correction factor (14%) due to the iterative QSM processing approach [67], the 
slopes become 1.03±0.03 (0.89 / (1-14%) = 1.03) and 1.08±0.06 (0.93 / (1-14%) = 1.08) ppb/µg 
Fe/g wet tissue, respectively. Those slopes are also very close to recent studies by Zheng et al. 
[67] and Langkammer et al. [108]. In their studies, the susceptibility-iron correlation was 
investigated by ferritin phantoms and cadaveric brains, and the iron concentrations were 
measured by inductively coupled plasma mass spectrometry (ICPMS) and X-ray fluorescence 
(XRF). The slopes reported were 1.11 ppb/µg Fe/g wet tissue (ferritin, ICPMS), 1.10 ppb/µg 
Fe/g wet tissue (ferritin, XRF), 0.93 ppb/µg Fe/g wet tissue (cadaveric, XRF) and 0.96 ppb/µg 
Fe/g wet tissue (cadaveric, ICPMS).  
The consistency across sites in measuring iron with QSM suggests that this may be the best 
approach to do iron quantification both in vivo and in vitro. Although R2* has been shown to 
also correlate well with iron content, in either small or large amounts, it may not fare as well. For 
example, for 3T magnetic, Langkammer et al. [55] reported a correlation slope of 0.27Hz/µg 
iron/g wet tissue according to a postmortem study, while Peran et al. [61] and Yao et al. [62] 
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reported the slope as 0.1142Hz/µg iron/g wet tissue and 0.120Hz/µg iron/g wet tissue 
respectively with in vivo data. The differences slopes between studies may be caused by that R2* 
depends not only on iron content but also on the water content and tissue composition. In 
addition, R2* values will change as a function of field strength [62], while magnetic 
susceptibility will always yield the pristine susceptibility, at least in theory. 
Comparing the susceptibility values with iron concentration published by Hallgren & Sourander 
is a popular approach to find the in vivo conversion factor. However, people always quote the 
average iron concentration calculated from all 81 subjects with the age range of 31 to 100 years 
for different gray matter nuclei [7]. This is not an appropriate way to find the correlation because 
the average susceptibility values they had were not calculated from the subjects with the same 
age distribution [106, 107, 109, 113] and the fact that iron deposition in gray matter nuclei 
changes throughout the lifespan. Also, the sample sizes in those studies were small, only a few 
cases were included. On the other hand, in this current manuscript, the average iron 
concentration for each decade was calculated on the basis of Hallgren & Sourander’s scatter 
plots. With this method, the age distributions are matched and more data points are used for 
fitting (30 points), which ensures a more reliable conversion factor between the susceptibility 
and iron concentration.  
Another method proposed in this study to find the susceptibility-iron correlation is by estimating 
the iron concentration from the age equations provided in Hallgren & Sourander’s paper [7]. The 
disadvantage of this method is that there is no one to one match for each individual because the 
equation can only represent the mean iron concentration throughout the lifespan. Because of this 
we have to choose a structure which shows a strong age dependency. With the large sample size 
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of 175 and strong age dependent characteristic in PUT, a reasonable quantitative correlation 
between the magnetic susceptibility and iron content was seen. 
Finally, we can make some comments about the potential susceptibility of the CSF thanks to the 
strong linear relationship of susceptibility with iron between tissues. The intercepts 
(െ48.51ሺേ4.09ሻ and െ59.49ሺേ6.43ሻ ppb) indicated by the linear fitting equations from the two 
approaches can be used as an estimate of the susceptibility of the CSF. Since CSF is pure water 
and doesn’t contain iron, it can serve as a baseline for estimating absolute iron deposition in 
other brain structures. There are basically three regions that can be used to measure the CSF 
susceptibility from the QSM maps: the body of the lateral ventricle, the ventricle next to the CN 
and the CSF in the sulci in the upper brain. The body of the lateral ventricle contains choroid 
plexus, so finding consistent values there was difficult. Also due to the filter size chosen for 
SHARP processing is comparable to the sizes of gray matter nuclei and the body lateral ventricle 
is such a big structure, the susceptibility will be potentially modified. The size of the CSF in the 
sulcus is only a few pixels and sometimes veins pass through it.  
 
Limitations 
One of the limitations of this study is the lack of young subjects. However, by combining Li et 
al.’s recent study [77], promising susceptibility trends with age are revealed in gray matter nuclei.  
Another limitation is the lack of multi-echo data, so we couldn’t provide the comparison between 
magnetic susceptibility and regional R2* in this study. However, in Li et al.’s in vivo study [77], 
the correlation between R2* and susceptibility was suggested by a conversion slope of 
0.1267Hz/ppb ( R2∗ ൌ 0.1267χ ). As we have shown in Figure 5.4, our susceptibility 
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measurements are comparable with theirs, so the susceptibility we measured can be converted to 
R2* according to their calculations. In addition, Peran at al [61] published a correlation between 
R2* and iron concentration for in vivo data with a slope of 0.1142Hz/µg iron/g wet tissue. In 
Peran at el.’s work, iron concentrations were derived from published post-mortem data [7] in a 
function of age. By combining the two relations, we have 0.1267χ ൌ 0.1142 ∗ Fe, then 
χ ൌ 0.90 ∗ Fe 
where shows by correlating our susceptibility measurements with R2* and then correlating with 
iron on the basis of published correlations, the susceptibility/iron correlation is 0.90 ppb/µg Fe/g 
wet tissue. This is very close to what we have found with our in vivo data: 0.89±0.03 ppb/µg 
Fe/g wet tissue by the age bin method and 0.93±0.05 ppb/µg Fe/g wet tissue by the iron-age 
function method (Hallgren and Sourander, 1958) in PUT.  
 
Conclusion 
The results of this study show that QSM is a reliable approach to do iron quantification and it is 
independent of imaging parameters. Iron is directly correlated with magnetic susceptibility, 
therefore, iron quantification can be done by QSM without the need for the postmortem iron 
study by Hallgren and Sourander anymore. The susceptibility-age correlations revealed from the 
175 normal subjects studied here can serve as a basis for determining normal iron content as a 
function of age that can be used to help determine abnormal iron content levels in diseases that 
affect iron content in the brain.  
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Chapter Six    Patterns of chronic venous insufficiency in the dural sinuses and 
extracranial draining veins and their relationship with white matter 
hyperintensities for patients with parkinson's disease 
Introduction 
Idiopathic Parkinson's disease (IPD) is the second most common neurodegenerative disease after 
Alzheimer’s disease, and it affects roughly 0.1% to 0.3% of the population[14]. The main known 
risk factor is age. The etiology of IPD remains unknown. Generally, Parkinson’s patients (PD) 
show a loss of dopaminergic neurons in the substantia nigra pars compacta, a reduction of 
dopamine levels in the striatum over time[115] and accumulation of intraneuronal inclusions 
called Lewy bodies and Lewy neurites[116]. Although clinically PD is a motor disorder and has 
a good response to dopaminergic therapy, in the advanced stages of PD most of the motor 
disability symptoms don’t respond to dopaminergic therapy anymore[116]. There are also many 
non-motor problems, such as cognitive impairment, autonomic dysfunction, neuropsychiatric 
symptoms[117] and fatigue[118] for patients in both early and advanced stages. These findings 
suggest the dopaminergic system may not be the only system involved in the PD process.  
It has been shown that there is an increased presence of white matter hyperintensity (WMH) in 
IPD patients[20]. The suggested causes for these deficits include ischemia and venous 
insufficiency from periventricular venular collagenosis[21-23]. WMH might cause or exacerbate 
motor or cognitive features of PD[119] especially in the presence of gray matter vascular lesions 
involving the substantia nigra or striatum[120], corticostriatal-thalamocortical loop disruption, 
damage to the interhemispheric connections of the corpus callosum[119], or disruption of the 
subcortical afferents . If typical late-onset PD patients have a history of minor stroke, ischemic 
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heart disease, or diabetes mellitus, they show more severe clinical features[121]. One group 
found that the severity of WMH at baseline was the best predictor of PD progression[24].  
In the last few years, there has been an increasing interest in the role of veins in 
neurodegenerative diseases[12], and more attention has been paid to the extracranial veins such 
as the internal jugular veins (IJVs) and the azygous veins as being potential sources of venous 
hypertension[9, 11, 12]. Obstructed venous outflow in the extracranial veins was reported to 
correlate significantly with hypoperfusion in the brain parenchyma which could contribute to 
hypoxia and axonal damage[122, 123]. Additionally, venous hypertension in the dural sinuses 
inhibits the absorption of CSF through arachnoid villi. Some studies showed an association 
between the venous outflow disturbances with low net CSF flow in patients with MS[124, 125]. 
An important aspect of the venous abnormalities is that they are potentially treatable with 
percutaneous transluminal angioplasty (PTA)[126]. The first application of PTA in the major 
cerebral veins was done by Zamboni et al in 2009 in MS patients with CCSVI[127]. Since then, 
a few studies have shown improvement in neurological outcomes and/or some quality-of-life 
parameters in MS patients who underwent PTA[127-129].  
The use of MR angiography (MRA) and phase contrast flow quantification (PCFQ) for the study 
of the vasculature in patients with PD is a novel concept spurred, in part, by our recent work in 
multiple sclerosis (MS) patients[13]. By applying flow encoding in the PC sequence, the 
intensity of the phase images is directly proportional to the speed[130]. The phase intensity in 
radians is then scaled to velocity using the relationship v=phase(Venc/π), in which Venc stands 
for velocity encoding. By positioning these 2D PC-MRI flow slices roughly perpendicular to the 
vessels in the neck, flow in all major vessels can be quantified. Using these morphologic and 
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functional MRI techniques, we can not only obtain the anatomic vascular information but also 
the quantitative arterial and venous blood flow.  
To this end, we proposed this preliminary study with a group of 23 IPD patients to see if some of 
these patients have abnormal structure or flow either intracranially and extracranially. The 
outcomes from this study have the potential to open new doors in studying the vascular etiology 
of IPD. 
 
Methods 
Recruitment of patients and controls 
From May, 2011 to March, 2013, 40 IPD patients were recruited and scanned. Fifteen patients 
did not receive a complete set of scans due to motion or termination because of patient 
discomfort. Two IPD patients were excluded because they were scanned after taking medication. 
By excluding those cases, we finally included 23 IPD cases and for this reason 23 age-matched 
healthy subjects were included in this study. They were all recruited and imaged at Wuhan Union 
Hospital, China. The patients with clinically definite IPD were diagnosed by a neurologist at 
Wuhan Union Hospital based on the United Kingdom PD Society Brain Bank Criteria 
(UKPDSBB). The patients and controls were imaged under internal review board approved 
protocols.  
Patients who fulfilled the UKPDSBB criteria were included. However, patients who had any of 
the following conditions were excluded from this study: any element of the exclusion criteria 
listed in UKPDSBB; patients with other neurological disorders such as Huntington's disease, 
multiple sclerosis, normal pressure hydrocephalus; drug-induced Parkinsonism; hypoxia; 
arteriosclerotic disease; hypertension or diabetes because excessive WMH may show in those 
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patients. The following conditions were excluded for normal controls: history of cardiovascular, 
neurological or psychiatric conditions; head trauma; hypertension; diabetes; drug or alcohol 
problems. 
All patients and controls consented to be subjects in this study. A 3T Siemens scanner with a 16 
channel head/neck coil arrangement was used for acquiring the data (Siemens TRIO). Patients 
underwent conventional clinical imaging as well as angiographic (arterial and venous) and flow 
quantification imaging. The imaging parameters for each sequence are listed in Table 6.1. The 
MRI images of the patients were acquired before taking medication.  
Table 6.1: MR imaging parameters for different sequences.  
 2D TOF-MRV T2-FLAIR (21 PD patients)
T2-FLAIR 
(2 PD patients, 
23 normal 
controls) 
SWI PCFQ at C6/C7 
Orientation Transverse Transverse Sagittal Transverse Transverse
TR (ms) 26 8500 6000 29 42.25 
TE (ms) 5.02 93 396 20 4.13 
Flip Angle 60° 130° 120° 15° 25° 
Resolution (mm3) 0.5x0.5x2.5 0.43x0.43x5 0.5x0.5x1 0.5x0.5x2 0.57x0.57x4
Bandwidth (Hz/pixel) 217 287 781 119 531 
An arterial saturation band with a width of 40mm and a separation of 10mm from the excited 
slice was applied during 2D TOF-MRV acquisition. A maximum encoding velocity (VENC) of 
50cm/sec was used for PCFQ. 
 
Data processing and analysis 
Data processing was done using our in-house software Signal Processing in Nuclear Magnetic 
Resonance (SPIN, Detroit, Michigan). WMH were evaluated from the 2D FLAIR images. The 
total volume of WMH was calculated semi-automatically by SPIN. As the FLAIR data were 
collected with different resolutions, all the data were normalized to 1x1x5mm3 (transverse in-
plane) before doing the volume quantification. In addition, the MRI visual rating scale proposed 
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by Scheltens et al.[131] was also used for evaluating the WMH level, which takes the number, 
size and location of the WMH into account. The modified visual rating criteria are presented in 
Appendix 1. The 2D TOF data were used for evaluating the venous structures in the head and 
neck. A saturation band was applied to suppress the arterial flow in the 2D TOF images. The 
maximum intensity projection (MIP) of the whole series was generated in the coronal view from 
the 2D TOF coverage. The major veins of interest for the structural analysis included the 
transverse sinuses and the extracranial veins in the neck. 
The PCFQ images were used to analyze the through-plane blood flow in the lower neck (C6/C7). 
Thirty time points were collected for each cardiac cycle. Cardiac gating was achieved using 
pulse triggering. Background muscle was used to monitor the baseline to ensure there was no 
bulk drift over time. We chose 50cm/sec as the Venc because this gave much better SNR for 
venous flow than 100cm/sec, and flow in the arteries could still be unwrapped when aliasing 
occurred, which was done automatically with SPIN. The vessels of interest included (Figure 6.1): 
the internal and external jugular veins (IJVs, EJVs), vertebral veins, deep cervical veins, 
common carotid arteries and vertebral arteries. The vessel lumen was segmented from the 
magnitude images (Figures 6.1A and 6.1C) semi-automatically thanks to the presence of 
sufficiently high contrast and copied onto the phase images (Figures 6.1B and 6.1D).  
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Figure 6.1:  PCFQ images without (A, B) and with (C, D) vessel contours used for blood flow 
quantification. A and C are magnitude images. B and D are phase images. Vessels of interest for 
this case include: internal jugular veins (solid down arrows), external jugular veins (up chevron 
arrows), common carotid arteries (notched down arrows), and vertebral arteries (up solid arrows). 
In this case, the right IJV has circulatory flow (blood flowing toward the brain) as shown by the 
black arrow in the phase image. 
 
The MR flow technique we use gives a pixel by pixel flow for each vessel. From each pixel we 
get flow as a function of the cardiac cycle. From this data, for all vessels, we can obtain 
integrated flow over the entire cardiac cycle (ml), volume flow rate (ml/sec) and both positive 
and negative volume flow rates (ml/sec). The positive volume flow rate in the IJVs was used to 
establish the criteria for circulatory flow. Circulatory flow represents the situation where there is 
simultaneously positive and negative flow present within a vein. On the PC phase images, the 
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vein with circulatory flow shows dark and bright signal areas (Figure 6.1D), and based on the 
positive volume flow rate plot, the vein has at least 4 time points with positive flow higher than 
2ml/sec and positive flow (toward the brain) present for at least half of the cardiac circle. 
Example plots of the key parameters over a full cardiac cycle are shown in Figure 6.2. Figure 
6.2A(3) shows the positive flow plot for an example with circulatory flow. The venous flow was 
normalized by the total arterial flow (tA), which was defined as the sum of the flow in the 
common carotid arteries and vertebral arteries. In addition, the ratio between the dominant and 
sub-dominant IJVs (Fd/Fsd) was calculated. Dominant IJV represents the IJV which carries the 
most outflow, and the sub-dominant IJV is the one with less outflow.  
Based on the anatomic information from the 2D TOF and the quantitative IJV flow, the IPD 
patients and normal controls were separated into 4 categories. Examples from each of these IJV 
abnormalities are shown in Figure 6.3A-D. In defining the category types from a venous 
anatomy and flow perspective, flow thresholds and cross section thresholds were defined. An 
Fd/Fsd ratio greater than 4 was taken to be abnormal. We determined the Fd/Fsd threshold based 
on the receiver operator characteristic (ROC) curve analysis of the patients and controls, and 4 
represented the optimal cutoff to distinguish between the two populations. The work of Seoane et 
al[132] suggested a factor of 3:1 for dominant to sub-dominant transverse sinus flow as a risk 
factor. IJVs are continuation of transverse sinus, so our result is not inconsistent with their 
findings. The threshold of normalized sub-dominant IJV flow (Fsd/tA) was calculated from the 
normal controls by subtracting the standard deviation from the mean (0.24 – 0.10 = 0.14). An 
IJV was called stenotic if the cross-sectional area was less than 12.5mm2 for the upper neck or 
less than 25mm2 for the lower neck[13]. Based on these quantitative data and our general 
observations, we considered the following four categories as representative of the data. 
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Figure 6.2: A: Plots of the integrated flow (A(1)), volume flow rate (A(2)) and positive volume 
flow rate (A(3)) of the vessels of interest over a full cardiac cycle at C6/C7 for the same case 
shown in Figure 6.1.  B: The same types of plots as shown in A but for a case without circulatory 
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flow. Please note that comparing the positive volume flow rate between Case A and Case B, the 
positive flow in the right IJV with circulatory flow (arrows in A(3)) is much higher IJV without 
circulatory flow.  
 
Category 1: All the following conditions must be met: 1) one or both transverse sinuses do not 
appear on the TOF; 2) one or both sigmoid sinuses are not shown on the TOF; 3) absence or 
local absence of IJVs on the TOF; 4) Fd/Fsd at C6/C7 is greater than 4 and Fsd/tA is less than 0.14, 
or circulatory flow in one or both of the IJVs. In the example case shown in Figure 6.3A(2), 
there is no left transverse sinus and no left sigmoid sinus on TOF. The upper left IJV is severely 
stenotic (left arrow) and the top part is absent, and some other small veins reconstitute the left 
IJV at the lower level. In this case, Fd/Fsd = 13.85. 
Category 2: All the following conditions must be met:  1) one or both transverse sinuses do not 
appear on the TOF; 2) sigmoid sinuses appear on the TOF; 3) there is banding in the IJVs (this 
represents very slow blood flow) and/or the presence of stenosis along the IJVs; 4) same as 
Category1 criteria(4). In the examples shown in Figure 6.3B(1), the left transverse sinus is 
missing or invisible although the left sigmoid sinus is present. A banding artifact is evident in 
almost the entire left IJV, which may be caused by an oscillatory or slow flow. The left sigmoid 
sinus and the left IJV are much narrower than the right. The presence of a transverse sinus cannot 
be ruled out without the use of a contrast agent, but there may be reduced flow that makes it 
difficult to visualize with 2D TOF. Nevertheless, this slow flow may still be manifest in the 
reduced flow visualized here. In this case, Fd/Fsd = 21.1. 
Category 3: All the following conditions must be met: 1) sigmoid sinuses appear on the TOF; 2) 
same as Category1 criteria(4). In the example case shown in Figure 6.3C, part of the left 
transverse sinus appears to be missing due to slow flow or just in-plane flow, the left sigmoid 
sinus is visible and Fd/Fsd = 4.39. 
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Category 4: All the following conditions must be met: 1) the transverse sinuses and sigmoid 
sinuses appear on the TOF; 2) the IJVs are not stenotic; and 3) Fd/Fsd at C6/C7 is less than 4 and 
and Fsd/tA is bigger than 0.14. The Fd/Fsd of the example shown in Figure 6.3D is 2.1.  
Except for category 4, all the other 3 categories contain some structural or flow abnormalities. 
Categories 1, 2 and 3 are ranked based on the severity of the vascular structural abnormalities 
with the abnormality in Category 1 being the most severe.  
 
Figure 6.3: A-D: Example cases from each of four categories and different abnormal IJV 
conditions shown in the coronal projection of the 2D TOF images. A: two cases from Category 1, 
A(2) Fd/Fsd = 13.85. B: two cases from Category 2, B(1) Fd/Fsd = 21.1. C: A Category 3 case, 
Fd/Fsd = 4.39. D: A Category 4 case, Fd/Fsd = 2.1. A(1): missing left IJV. A(2): stenotic left IJV 
(white arrow in A(2)). B(1): banding artifact in the left IJV. The right IJV is big and the signal is 
uniform, so the banding artifact in the left IJV is caused by abnormal flow, not by swallowing or 
respiratory artifact. B(2): uneven signal contrast in the left IJV. Compared to the right IJV, the 
signal in the left IJV is not uniform and has a stenosis (white arrow in B(2)).  
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Statistical analysis 
The optimal cut-off values for Fd/Fsd, WMH volume and WMH visual score to separate IPD 
patients and controls were determined using a ROC analysis. An unpaired t-test was used to test 
the difference between the two populations for age, tA, common carotid arterial flow, vertebral 
arterial flow, normalized total IJV flow (tIJV/tA), normalized left IJV flow (LIJV/tA), Fd/Fsd, 
normalized collateral venous flow, and WMH visual score. A paired t-test was applied to test the 
difference between LIJV and RIJV. The categorization distribution difference between IPD 
patients and the normal controls was analyzed by Chi-squared test. A Wilcoxon Rank-sum test 
was used to test the WMH volume difference between patients and controls because of outliers.  
 
Results 
The age range of the IPD patients was 43 to 74 yr with a mean age of 62.6 yr and standard 
deviation of 8.3 yr. For the normal subjects, the age range was 56 to 81 yr and the age mean was 
64.1 yr with a standard deviation of 6.7 yr. There is no statistical age difference between the two 
populations (p=0.48).  
Category Analysis 
The categorization distribution of the IPD patients along with the normal subjects using the 
criteria defined above is shown in Figure 6.4A. Based on the venous anatomic characteristics and 
asymmetric flow in the IJVs, there were clearly 4 categories with different severity of venous 
vasculature. However, with a small number of subjects in some categories, the distribution 
comparison between the patients and controls may not be applicable. We summed up the subject 
number in categories 1 to 3 which represent the ones with both anatomic and/or flow 
abnormalities and then did the comparison. For normal controls, 30% were in categories 1 to 3, 
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and 70% in category 4; for the PD patients, 57% were in categories 1 to 3 and 43% belonged to 
category 4. According to the Chi-squared analysis, these two populations are significantly 
different (χ2=7.70, p < 0.01).  
Quantitative Flow Analysis 
The tA for the IPD patients and normal subjects were 14.67±2.49 ml/sec and 16.25±2.1 ml/sec, 
respectively, and there was significant difference between them (p=0.04). The average flow in 
the common carotid arteries was 5.98±1.26ml/sec in IPD patients and 6.51±1.12ml/sec in 
controls. The blood flow in the common carotid artery was significantly larger (p=0.04) in the 
normal people than in the IPD patients. The average flow in the vertebral arteries was 
1.39±0.65ml/sec and 1.57±0.76 in the IPD patients and normal subjects, respectively, and there 
was no significant between them. The tIJV and tIJV/tA for the normal controls was statistically 
higher than the patients (IPD: 10.85±3.29ml/s, normal controls: 13.54±2.14ml/s, p<0.01; IPD: 
0.74±0.17, normal controls: 0.84±0.14, p=0.03).  
The normalized flow of the right IJV was found to be significantly larger than the left IJV for 
both IPD patients (0.56±0.16 vs. 0.18±0.16, p<.0001) and the normal population (0.52±0.2 vs. 
0.32±0.19, p=.01). The LIJV/tA was significantly higher in the normal controls (IPD: 0.18±0.16, 
normal controls: 0.32±0.19, p=0.01). Another measure of flow variation between the left and 
right IJVs is the ratio of the two IJVs, Fd/Fsd. Since Fsd can become quite small in some cases, we 
restricted the ratio to be 10:1 when performing the average values so as not to skew the data (this 
ratio was set to 10:1 for 8 PD patients and only 1 normal control). This ratio is significantly 
larger in IPD patients than in normal controls (p =.04). Figure 6.4B shows the scatterplot of 
dominant vs. sub-dominant IJV flow for the normal controls and IPD subjects.  
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According to the four vascular categories we defined, Category 1 and Category 2 contain the 
conditions of: IJV stenosis or missing IJVs, so we refer to patients in Category 1 and 2 as 
stenotic patients and patients in Category 3 and 4 as non-stenotic patients. According to Figure 
6.4B, the stenotic patients showed much higher Fd/Fsd than the non-stenotic patients. For the tIJV 
and tA, there is no significant difference found between the stenotic and non-stenotic patients 
(tIJV: 10.2±4.4ml/s vs. 11.3±2.4ml/s, p=0.52; tA: 14.7±4.4ml/s vs. 14.6±1.7ml/s, p=0.96).  
The category type appears to correlate well with Fd/Fsd (Figure 6.4C), which indicates that the 
higher the Fd/Fsd ratio, the more likely the patient sits in the severe abnormal structural and flow 
categories.  
 
Figure 6.4: A. Distribution of the IPD patients and normal controls according to the defined 
categories. The normal population lies predominantly in category 4. Most IPD patients are 
distributed in categories 1to 3 which have venous structural or flow abnormalities.  
B. Scatter plot of dominant IJV vs. sub-dominant IJV flow at C6/C7 neck level in IPD patients 
(circle) and normal controls (cross). The higher black line represents the Fd/Fsd=4:1. Comparing 
to the normal subjects (5 out of 23 cases lie below the 4:1 ratio line), a higher percentage of the 
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IPD patients (11 out of 23 cases: 48%) showed Fd/Fsd greater than 4:1. Moreover, all the patients 
with stenosis in the IJVs (solid circles) lie below the line indicating that they have more severe 
asymmetric flow in the IJVs. The lower black line represents Fd/Fsd=10:1. In this case, all but 
only one stenotic PD case falls below the 10:1 line and only one normal falls below this line. 
C: Scatterplot of category vs. Fd/Fsd for the 23 patients. They have good correlation (R2=0.72), 
which indicates that patients with higher Fd/Fsd tend to be in the category with more severe 
venous structural and flow problems. 
 
Correlation between FLAIR WMH and categorization 
Of the 23 IPD cases, 21 showed WMH. The mean, median and standard deviation of WMH 
volume in IPD patients were 5827mm3, 502mm3 and 10755mm3 with a range of 0 mm3 to 
42177mm3. The mean, median and standard deviation of the WMH volume in the normal 
controls were 776mm3, 265mm3 and 1358mm3 with range of 0mm3 to 6147 mm3. There is a 
significant difference between the two populations according to the Wilcoxon rank-sum test 
(p=.04). The IPD patients and normal controls were further divided into a high WMH volume 
group and a low WMH volume group. The threshold for this separation was set to 500mm3, 
which was determined by an ROC analysis between the normal controls and PD patients. The 
distribution of the patients and normal controls with high and low WMH volume along with the 
category type is shown in Figure 6.5A. 
The WMH visual score for the IPD patients was 5.8 ± 5.3, while the score of the age-matched 
normal controls was 3.1 ± 3.0. There is significant difference between the two populations for 
the WMH visual rating (p=0.05). Moreover, all the patients in Category 1 showed a WMH visual 
score greater than or equal to 4. The distribution of patients with low WMH score (<=3) and high 
WMH score (>=4) according to their categorization is shown in Figure 6.5B. We chose a score 
of 3 as the threshold because it could best separate the patients’ categorization distribution.  
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Figure 6.5: A: The distribution of IPD patients and normal controls with low WMH volume 
(<500mm3) and high WMH volume (>=500mm3) for different categories. Majority of Category 4 
patients and normal controls contain low WMH volume, while more of the patients in Categories 
1 to 3 show high WMH volume. B: The distribution of IPD patients and normal controls with 
low WMH visual score (<=3) and high WMH visual score (>=4) for different categories. All the 
patients in Category 1 have high WMH visual scores. For patients in Categories 2 and 3, more of 
the patients show high WMH scores.  
 
Discussion 
This paper is the first to study venous abnormalities on patients with IPD. The categorization 
defined in this work could help distinguish IPD patients from normal controls: 70% of the 
normal controls appeared in Category 4, while 57% of the IPD patients belonged to Category 1 
through 3 (those containing venous structural and/or venous flow abnormalities). In addition, 
those patients with higher WMH scores tended to be in Category 1 through 3, which indicates a 
likely correlation between the vascular abnormalities and brain WMH. Moreover, 3 cases with 
Fd/Fsd less than 4 and a WMH score higher than 4 showed circulatory flow in at least one of the 
IJVs. The combination of structural abnormalities, asymmetric IJV flow, and abnormal 
hemodynamics such as circulatory flow could together be a major risk factor for developing 
WMH and perhaps even the disease itself.  
Not all PD patients showed these flow abnormalities. However, PD is not a disease but a 
syndrome and there may be many sources for its development. In this light, one may consider 
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CCSVI to be just a co-morbidity associated with PD. As for the normal controls, there is 
definitely an overlap with categories 1 through 3. If one used this to determine who might get PD 
or neurodegenerative disease, normal controls seen these three categories would be incorrectly 
assessed. But we have no way of telling today where they will sit 20 or 30 years from now. 
Our finding of the asymmetric pattern of the IJV flow is consistent with many other research 
publications since a majority of individuals are right dominant[133]. However, the flow ratio 
between the two IJVs (Fd/Fsd) of IPD patients is significantly higher than the normal controls. 
Moreover, patients with vascular stenosis have significantly higher Fd/Fsd than the non-stenotic 
patients. 
Recently, more attention has been paid to venous collaterals[134, 135]. By developing a model 
to calculate the venous collateral flow, which is normalized to the tA, a collateral flow index 
(CFI) has been compared between normal controls and MS patients with CCSVI. In the supine 
position, the patient's CFI was reported to be significantly higher than the normal controls (61%, 
p<0.0002)[134]. As our data was also collected in the supine position with quantitative flow in 
the common carotids, vertebral arteries, IJVs and vertebral veins, a similar type of comparison 
can be made between the IPD patients and the normal controls. In fact, we too found that the 
normalized collateral flow in the IPD patients was statistically higher than in the normal controls 
(0.26±0.17 vs. 0.16±0.14, p=0.03). One might well ask, “If the flow in the stenotic IJV and/or 
transverse sinus can be recovered, could PTA be a potential therapy for some of these 
patients?”[136, 137]  
The observation of the original criteria established by Zamboni et al. [10] are not directly 
observable by the methods which we have employed. While the original five CCSVI criteria 
mainly concern flow and stenosis patterns at the lower neck level in the IJV and vertebral veins 
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as well as the azygous vein, the observations which we have made constitute a new criteria 
which has only been shown in MRI thus far[133].  Whether or not similar findings could be 
made on ultrasound is unclear and needs further study, however given that a lack of venous 
outflow and structural abnormalities have been observed using MRI in the transverse sinus and 
IJV in our group of PD subjects the authors would expect that a similar observation would be 
possible with ultrasound. 
There are several different MRI visual rating scales for WMHs[131]. We chose Scheltens et al. 
for this study because it is quite commonly used[138]. In addition, according to Pantoni et al’s 
study[139], the four MRI rating scales referenced in their paper are well correlated. Although 
having WMH is not a standard clinical diagnostic criterion for IPD, in this study cohort,  21 
patients showed WMH, 5 had very high WMH volume (more than 10,000mm3) and of these 4 
had a high visual score (greater than 9). A study did by Piccini et al.[20] found a positive 
relationship between the WMH volume and PD symptom severity.  
According to many in vivo imaging studies, 30% to 55% of PD patients show WMHs[140], and 
some studies have suggested that WMH are more frequently present in patients with PD than in 
normal elderly individuals and hypertension patients[20, 141]. Our finding that IPD patients have 
higher WMH volume and visual score than normal controls is consistent with those studies. 
WMHs may represent either lacunar infarcts or other tissue damage in the thalamocortial motor 
system, a key area in the pathogenesis of Parkinsonian symptoms[115]. WMH are thought to 
relate to cardiovascular disease[22]. Young et al.[23] reported the association between WMH 
and loss of vascular integrity in a neuropathological study, which suggested a vascular origin for 
these lesions. An MRI-pathological correlation study by Gao et al.[21] demonstrated that focal 
and periventricular hyperintensities (PVH) often relate to venules and can increase or decrease 
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over time. They proposed that venous collagenosis dilates the veins, making them macroscopic 
and causing venous insufficiency with consequent vessel leakage and vasogenic edema[21]. 
These data support our findings where patients with venous structural and/or venous flow 
problems are more likely to have more WMHs. Other factors could affect the WMH scores 
besides venous abnormalities. However, it is believed that WMH especially in aging can be 
caused by reductions in perfusion to the brain[142]. 
Limitations and future directions 
There are a number of limitations to this study. First, the sample size is small. Nevertheless, even 
with this small number, we found clear abnormal venous vascular characteristics in IPD patients 
with significant differences from the normal subjects. This suggests that there is a prevalence of 
vascular abnormalities in patients with IPD. With a larger number of patients, it would be 
possible to study the correlation between the vascular problems with IPD sub-types. The second 
limitation is the lack of 3D time-resolved contrast-enhanced arteriovenography (3D CE MRAV) 
scans which could offer the advantage of acquiring separate arterial and venous phases and better 
delineate the dural sinuses. Even though 2D TOF causes reduced signal from in-plane flow, for 
patients with fast enough flow in the transverse sinuses (such as seen in many cases on the right 
hand side), we still expect some signal representing the anatomy of the vessels. Third, collecting 
flow in the transverse sinuses would also be useful to understand the fluid dynamics of the 
evidently abnormal venous flow on the left side.  
 
Conclusions 
In this paper, we have shown several key findings. First, that WMH correlate with venous 
jugular flow. And second, there are venous vascular abnormalities in patients with IPD that tend 
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not to be present in the normal population. More specifically, we found that 90% of the patients 
showed WMHs and that 57% of the patients had structural and/or venous flow abnormalities in 
the transverse sinus, sigmoid sinus and IJVs. Nevertheless, this is a preliminary work and further 
studies are required to confirm these conclusions. These findings may prove to be an important 
imaging means to sub-classify IPD patients, to enhance our understanding of the etiology of IPD 
and, perhaps, even lead to the development of new treatment regimens. 
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Chapter Seven    Conclusions and future directions 
 
In this thesis, two topics were covered: one was quantifying brain iron and the other one was 
imaging the vasculature characteristics in Parkinson’s patients using MRI. Two major projects 
were included for the first topic (Chapter 4 and Chapter 5) and one major project (Chapter 6) was 
done for the second topic.  Three approaches were used for measuring iron: ∆R2∗ (Chapter 4), 
phase (Chapter 4) and magnetic susceptibility (Chapter 5), which were all based on the SWI 
sequence.  
We investigated three MRI parameters’ (phase, ∆R2∗ and magnetic susceptibility) trajectories 
over the lifespan in seven brain gray matter nuclei: caudate nucleus (CN), putamen (PUT), 
globus pallidus (GP), red nucleus (RN), substantia nigra (SN), pulvinar thalamus (PT) and 
thalamus (THA). Phase, ∆R2∗ and magnetic susceptibility increased as a function of age in most 
of those structures, which suggested iron were accumulated in these structures as people getting 
old since there is direct correlation between these three MRI parameters and iron concentration. 
All the three parameters showed strong correlations with age in CN, PUT and RN. In GP, SN, 
PT and THA, the correlations were relatively mild. One exception was the THA. Susceptibility 
of THA decreased as a function of age. This was consistent with several previous studies [7, 82], 
however, further studies are needed to warrant the correlation. The phase-age, ∆R2∗-age and the 
susceptibility-age correlations revealed from the normal subjects in Chapter 4 and Chapter 5 can 
serve as a basis for determining the normal iron content as a function of age. The findings can 
help determine abnormal iron content levels in diseases that affect iron content in the brain. 
Besides the total ROIs, a more sensitive technique called two-region analysis was used to 
evaluate iron content change over time in the phase and ∆R2∗  study. The high iron content 
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region revealed two pieces of new information: both the average iron content per pixel and the 
area of high iron (RII) increased with age. Furthermore, in the high iron region of PUT, 
significant increase in iron uptake as a function of age was found for older adults past the age of 
40. 
QSM is a reliable approach to do iron quantification. It is independent of field strength, echo 
time, the object's geometry and the relative orientation to the main field. Although different 
centers may use different approaches to reconstruct susceptibility maps, the results are similar 
according (Chapter 5). The stability and consistency characteristics of QSM makes it possible to 
compare the quantification results across different types of magnets and different centers. 
According to the susceptibility measurements shown in Chapter 5, the highest iron deposition 
presents in the GP and then followed by the SN, RN, PUT, CN, PT and THA. The correlation 
between magnetic susceptibility and in vivo iron concentration found in this chapter was 
1.03±0.03 ppb/µg Fe/g wet tissue by the age bin method and 1.08±0.06 ppb/µg Fe/g wet tissue 
by the iron-age function method in PUT. The two slopes were close to each other and also 
comparable to other studies [67, 108].  
Finally, we studied the patterns of chronic venous insufficiency in the dural sinuses and 
extracranial draining veins and their relationship with white matter hyperintensities for patients 
with Parkinson's disease. The IPD and normal subjects were classified using both the MR TOF 
and PC images into four categories: 1) complete or local missing transverse sinus and internal 
jugular veins (IJVs) on the TOF images; 2) low flow in the transverse sinus and stenotic IJVs; 3) 
reduced flow in the IJVs; and 4) normal flow and no stenosis. When broken into the above 4 
categories with categories 1 through 3 combined, a significant difference in the distribution of 
the IPD patients and normal controls was observed. In IPD subjects, category type correlated 
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with both flow abnormalities and WMH. From this preliminary study, we conclude that a major 
fraction of IPD patients appear to have abnormal venous anatomy and flow on the left side of the 
brain and neck and that the flow abnormalities appear to correlate with WMH volume. 
 
Future directions:  
High iron content region in the normal brain 
Measuring iron using magnetic susceptibility is a continuation of using phase since the object 
susceptibility is the source of phase signal, and it is free from the non-local geometry effect. As a 
result, with QSM, it becomes possible to quantify iron in the 3D structures. In Chapter 5, we 
analyzed iron in the whole structures which can serve as a baseline for determining normal iron 
content as a function of age. However, to better understand the iron deposition pattern and to 
evaluate iron in a more sensitive manner, we need to apply the two-region analysis technique to 
the QSM data. This will be the next step of quantifying iron using magnetic susceptibility. 
Magnetic susceptibility thresholds for separating the low iron (RI) and high iron (RII) regions 
will be determined for each structure respectively, and for each structure, the thresholds are 
calculated separately for each decade. The reason to do this is different structures contain 
variable levels of iron content and iron deposition is age dependent. For each structure, a uniform 
area will be selected on multiple slices, and the average susceptibility per pixel and the standard 
deviation will be recorded. Then, a mean susceptibility value (Mean) will be calculated by 
averaging the mean susceptibility of all the subjects in that decade. A mean standard deviation 
(mSD) will be calculated by averaging the standard deviation of all the subjects in that decade. 
The threshold of a given decade for a given structure is determined by Mean minus two times of 
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the mSD (݄ܶ ൌ ܯ݁ܽ݊ െ 2 ൈ݉ܵܦ). The pixels with susceptibility higher than this threshold is 
defined as RII, which is the high iron content region since high susceptibility correlates with high 
iron concentration.  
The average susceptibility in RII and the normalized volume (normalized to the total volume of 
the structure) of RII will be plotted as a function of age for each structure of interest. Those plots 
can serve as a basis of determining abnormal RII iron deposition. The two-region analysis is 
more sensitive to subtle iron changes comparing to the total ROI analysis which would average 
out the local high iron deposition. Together with the total ROI baseline reported in Chapter 5, RII 
iron baselines will provide valuable clinical information for the detection of abnormal brain iron 
deposition in neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease, 
multiple sclerosis and so forth.  
Dural sinuses abnormalities in PD patents 
In Chapter 6, we studied the anatomical abnormalities in the dural sinuses of PD patients. Based 
on the preliminary TOF data, we found that a fraction of PD patients show absence or partial 
absence of transverse sinuses. This may be caused by the structural abnormalities or slow flow in 
the transverse sinuses. Without CE-MRAV and PCFQ at the dural sinuses (including transverse 
sinuses, sigmoid sinuses, straight sinus, superior sagittal sinus), it’s impossible to determine the 
real causes. As a result, we are planning to preform CE-MRA and PCFQ to 50 IPD patients and 
50 age and gender matched normal controls. For the anatomical MRAV analysis, arterial and 
venous phases of the 3D CE MRAV will be identified. Images will be subtracted to separate 
veins from arteries in order to identify any possible normal variants along the venous drainage 
system or the presence of stenosis. The 3D data will be Mipped over many slices to get a better 
overview of the drainage system. For the dural sinuses flow quantification, through-plane PCFQ 
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will be performed for the superior sagittal sinus (SSS), the straight sinus and the both left and 
right transverse sinus and sigmoid sinus. The anatomical features and the quantitative flow will 
be compared between the IPD patients and the normal controls to verify our preliminary findings 
in Chapter 6.  
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APPENDIX A: MODIFIED VISUAL RATING SCALE FOR WMH 
PROPOSED BY SCHELTENS ET AL [131, 139] 
 
WMH in periventricular and deep white matter are scored separately as are the scores for 
different lobes (the basal ganglia are also included in this assessment). The maximum score for 
the former is 6 and the latter is 30 as outlined below. Note that the latter has five separate regions, 
the frontal lobe, parietal lobe, occipital lobe, temporal lobe and basal ganglia. 
Periventricular Hyperintensities (Minimum, 0; Maximum 6) 
 No caps in the occipital lobe ---- 0 
 Caps in the occipital lobe less or equal than 5mm ---- 1 
 Caps in the occipital lobe greater or equal than 6mm and less than 10mm ---- 2 
 No caps in the frontal lobe ---- 0 
 Caps in the frontal lobe less or equal than 5mm ---- 1 
 Caps in the frontal lobe greater or equal than 6mm and less than 10mm  ---- 2 
 No bands at the lateral ventricles ---- 0 
 Bands at the lateral ventricles less or equal than 5mm ---- 1 
 Bands at the lateral ventricles greater or equal than 6mm and less than 10mm ---- 2 
The same criteria is applied for the frontal lobe, parietal lobe, occipital lobe, temporal lobe and 
basal ganglia 
Deep White Matter Hyperintensities (Minimum, 0; Maximum, 30) 
 No lesion in the region being studied ---- 0 
 Number of the lesions less/equal than 5, size of the lesions less/equal than 3mm ---- 1 
 Number of the lesions more/equal than 6, size of the lesions less/equal than 3mm ---- 2 
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 Number of the lesions less/equal than 5, size of the lesions greater/equal than 4mm and 
less/equal than 10mm ---- 3 
 Number of the lesions more/equal than 6, size of the lesions greater/equal than 4mm and 
less/equal than 10mm ---- 4 
 At least one lesion larger than 11mm ---- 5 
 Lesions are confluent ---- 6 
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ABSTRACT 
MEASURING BRAIN IRON IN HEALTHY CONTROLS AND ASSESSING VENOUS 
ABNORMALITIES IN PARKINSON’S DISEASE USING MRI 
by  
MANJU LIU 
August 2014 
Advisor: Dr. E. Mark Haacke 
Major: Biomedical Engineering 
Degree: Doctor of Philosophy 
Iron plays a key role in a number of brain cellular processes. However, abnormal brain iron 
regulation correlates with a number of neurodegenerative diseases such as Parkinson’s disease, 
multiple sclerosis and so forth. To further elucidate the involvement of iron in neurodegenerative 
disorders, a robust in vivo quantitative non-invasive assessment of normal brain iron deposition 
over time is essential. A variety of magnetic resonance imaging (MRI) methods have been used 
to quantify iron both in vivo and in vitro non-invasively. We first created the baseline of phase 
value and ∆R2∗ as a function of age in seven gray matter nuclei. We also studied how the high 
iron region in the structures change over time, which is a more sensitive way to study the brain 
iron deposition. Quantitative susceptibility mapping (QSM) is another approch we used to study 
normal brain iron deposition as a further step since susceptibility is a tissue property that is free 
from geometry effect and imaging parameters. Except in the thalamus, iron increases over time 
in the gray matter nuclei. We found iron content decreases as a function of age in thalamus 
according to the susceptibility measurements. These measured susceptibility values are also 
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compared with the regional iron concentrations taken from the histochemical post mortem study 
published by Hallgren and Sourander to establish an in vivo quantitative conversion factor 
between magnetic susceptibility and iron concentration. The correlation between the magnetic 
susceptibility and iron concentration found in this thesis is 1.03±0.03 ppb per µg iron/g wet 
tissue.  
Idiopathic Parkinson's disease (IPD) remains one of those neurodegenerative diseases 
where the cause remains unknown. Many clinically diagnosed cases of IPD are associated with 
cerebrovascular disease and white matter hyperintensities (WMH). In this thesis, we also include 
a study to investigate the presence of transverse sinus and extracranial venous abnormalities in 
IPD patients and their relationship with brain WMH. As a result of this preliminary study, we 
conclude that a major fraction of IPD patients appear to have abnormal venous anatomy and flow 
on the left side of the brain and neck and that the flow abnormalities appear to correlate with 
WMH volume.  
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